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ABSTRACT 
Courtney Lundquist: WHAT PRACTICES AND FACTORS LED TO BOTSWANA’S 90-90-90 
ACHIEVEMENT AND HOW CAN LESSONS LEARNED BE ADAPTED AND 
IMPLEMENTED IN OTHER SUB-SARAHAN AFRICAN COUNTRIES? 
(Under the direction of Sandra B. Greene) 
 
Botswana’s achievement of the UNAIDS 90-90-90 targets demonstrates that HIV 
epidemic control is possible in resource constrained countries. Resource deployment, 
attention to key populations, and the country setting (defined in this context as the political 
will, cultures and norms, laws, policies, actions, behaviors and health mechanisms), are 
factors that define the 90-90-90 achievement, and ultimately HIV epidemic control, 
ecosystem.  
Classified as an upper middle income (UMIC) country with stable social, government, 
and health care systems, the cultural backdrop in Botswana is different from many other 
sub-Saharan African (SSA) countries. These differences must be considered and accounted 
for when assessing the reproducibility of learnings from the Botswana HIV experience in 
other SSA countries. 
It is not practical, feasible, nor desirable for countries in SSA to reproduce exactly the 
specific practices and factors that led to Botswana’s 90-90-90 target achievement. To do so 
would require untangling country-level cultural DNA and reconstructing their communities, 
government, and “way of life” in the image and likeness of Botswana. Instead, SSA countries 
should learn from the Botswana HIV experience; aim to localize, adapt, and acculturate 
interventions based on the factors that cut across and influence the entire 90-90-90 
continuum (resources, setting description, and key populations), and; enable sustainable 
and effective practices to combat and control their HIV epidemic.  
iv 
Based on insights and lessons learned from the literature review, quantitative 
analysis of UNAIDS data, and key informant interviews with experts in Botswana’s HIV 
response, 90-90-90, and/or a combination of the two, this study presents an original 
framework and approach, named the HIV Epidemic Control Readiness Framework 
(HECRF). The HECRF is based on 13 third party, publicly available metrics, and designed 
as a tool to inform the sustainability and effectiveness of the HIV response in 46 SSA 
countries and signal: 1) how their HIV prevalence compares to other SSA countries, 2) 
where they score relative to other SSA countries in their progress towards 90-90-90, 3) 
where they score relative to other SSA countries in the sustainability and effectiveness of 
their HIV programs, 4) where they score relative to other SSA countries in their HIV epidemic 
control readiness and, 5) where increased focus and/or change agency - in areas related to 
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CHAPTER 1: INTRODUCTION 
Study Background 
The ultimate aim for an HIV treatment program is for people living with HIV (PLHIV) 
to be virally suppressed. When PLHIV achieve viral suppression, or a reduction in their HIV 
viral loads to undetectable levels, they have “effectively no risk” of sexually transmitting 
HIV1. For this to happen, PLHIV need to be diagnosed promptly, quickly receive antiretroviral 
treatment (ART), ongoingly engage with medical services, adhere to treatment, and have 
any difficulties with treatment regimens appropriately managed. These steps of care are the 
HIV testing and treatment cascade (sometimes referred to as the HIV care continuum) and if 
any of these steps are compromised, the benefits of treatment for the individual, and the 
prevention benefits for their sexual partners, and for the wider population, can be lost. 
90-90-90 draws on the HIV testing and treatment cascade and is an aggressive 
treatment target developed by the United Nations (UN) to enable countries to control 
Acquired Immunodeficiency Syndrome (AIDS) and Human Immunodeficiency Virus (HIV) by 
2030. 90-90-90 means “by 2020, 90% of all PLHIV will know their HIV status. By 2020, 90% 
of all people with diagnosed HIV infection will receive sustained ART. By 2020, 90% of all 
people receiving ART will have viral suppression.”2 Achieving these targets by 2020 will 
result in a global viral suppression rate of 73% for PLHIV, enabling the world to achieve 
epidemic control by 20302.  
The 90-90-90 targets and the HIV testing and treatment cascade are two methods of 
examining the same data3. In particular, the 90-90-90 targets were instrumental in 
galvanizing global action for HIV treatment access3. For each of the 90-90-90 targets, the 
denominator is different and contingent upon the status of the previous 90; across the testing 
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and treatment cascade, the denominator for each step remains the same: all people living 
with HIV3.  
Within the 90-90-90 target cascade, the first 90 value is the denominator for the 
second 90, and the second 90 value is the denominator for the third 90. This means that 
when a country achieves the second 90 of the 90-90-90 targets (i.e. the percentage of 
PLHIV who receive ART relative to the percentage of PLHIV who know their status), the total 
number of PLHIV receiving ART is only 81% (which is represented by the testing and 
treatment cascade). It follows that the third 90 in the 90-90-90 targets (the percentage of 
people who are on HIV treatment and are virally suppressed) is a function of the second 90, 
and if the first and second 90 are achieved, the third equates to an overall viral suppression 
of 73% for all PLHIV (which is reflected by the testing and treatment cascade).  
While HIV viral suppression of 73% of PLHIV is both remarkable and extraordinary, 
27% of patients do not achieve viral suppression. These patients are often in underserved 
HIV populations who experience inequitable access to care and sub-optimal health 
outcomes and may require special and enhanced effort to be treated2. Ensuring that no 
PLHIV is left behind requires continued attention to the testing and treatment cascade, even 
after 90-90-90 has been achieved. The serial 10% loss of projected coverage at each 
subsequent 90-90-90 step is not lost by the testing and treatment cascade, rendering both 
measurements important in tracking achievement toward HIV epidemic control: 90-90-90 
targets are designed to catalyze action toward HIV epidemic control and the HIV testing and 
treatment cascade is designed to report, in real terms, the number and percentage of PLHIV 
who are diagnosed, on treatment, and virally suppressed. The difference between the 90-90-
90 target cascade and the testing and treatment cascade is illustrated in Figure 1. 
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Figure 1: 90-90-90 Target Cascade versus HIV Testing and Treatment Cascade 
Globally, 37.9 million people were living with HIV/AIDS at the end of 2018, including 
an estimated 1.7 million newly infected individuals4. Sub-Saharan Africa (SSA) remains the 
most affected region, accounting for approximately 68% of the worldwide disease burden4. 
In 2018, with 20.6 million PLHIV, the region of Eastern and Southern Africa was home to 
54% of the world’s HIV population, and with five million PLHIV, Western and Central Africa 
accounts for a further 13% of the global HIV population4. Countries in Eastern and Southern 
Africa and Western and Central Africa are depicted in Table 1: Sub-Saharan Africa Regional 
Country List5. 
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Table 1: Sub-Saharan Africa Regional Country List 
 
Over the past 30 years, dramatic improvements have been made concerning the 
ability to prevent and treat HIV. In fact, treatment innovations, including fixed-dose 
combinations, improvements to previous drug classes (e.g. integrase inhibitors), the 
introduction of new and potent drug classes (e.g. entry inhibitors), and the advent of long-
acting injectables, have been so radically transformed that PLHIV on treatment can suppress 
their viral load to undetectable amounts purely by using ART as instructed by their health 
care provider6. HIV statistics collected by UNAIDS and published in June of 2019 showed 
23.3 million PLHIV were accessing ART globally7 – an increase from 15.8 million in June 
2015, 7.7 million in 2010, and less than one million in 20008. Based on these estimates, 
global achievement of the 90-90-90 goal would require a two to three-fold increase in viral 
suppression2, which translates into 18.8 million virally suppressed individuals in SSA. 
Unfortunately, this ambitious target is likely to be missed. 
By 2016, Botswana was one of seven countries globally to have achieved the 90-90-
90 viral suppression goal of 73% or greater for all PLHIV. Other countries that reached the 
target by 2016 included Cambodia, Denmark, Iceland, Singapore, Sweden and the United 
Kingdom of Great Britain and Northern Ireland9. In 2018, Botswana achieved 91%, 91%, and 
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>95% of the 90-90-90 targets, respectively10 (see Figure 2: Botswana’s progress toward 90-
90-90 targets (2015-2018)), equating to a test-and-treat cascade of 91% of PLHIV in 
Botswana being aware of their HIV status, 83% of all PLHIV following HIV treatment, and 
85% of all PLHIV being virally suppressed11 (see Figure 3: Botswana’s test-and-treat 
cascade (2015-2018)). As the first country in SSA to record this achievement, Botswana’s 
success is remarkable. 
 
Figure 2: Botswana’s progress toward 90-90-90 targets (2015-2018) 
 
Figure 3: Botswana’s test-and-treat cascade (2015-2018) 
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Purpose and Aims of This Study 
The purpose of this study is to contribute to the body of knowledge that supports the 
achievement of the 90-90-90 targets; develop an approach toward HIV epidemic control 
based on lessons learned from Botswana’s HIV experience that is adaptable to the unique 
and individual circumstances of SSA countries, and; identify ways different stakeholders 
involved in the HIV response can utilize the approach to support advancement of 90-90-90 
achievement and HIV epidemic control readiness in SSA, by answering the question: 
 
What practices and factors led to Botswana’s 90-90-90 achievement  
and how can the lessons learned be adapted and implemented  
in other sub-Saharan African Countries? 
The aims of this study are to: 
1. Describe the current state of 90-90-90 from a global, regional (sub-Saharan Africa), 
and country (Botswana) perspective and assess the robustness of data collected to 
track achievement of the 90-90-90 targets. 
2. Develop an in-depth case study to understand how Botswana achieved 90-90-90 and 
identify best practices responsible for this achievement. 
3. Develop an approach for recognizing, highlighting, and adapting lessons learned 
from Botswana to support stakeholders involved in the SSA HIV response to achieve 
the 90-90-90 targets and HIV epidemic control readiness. 
Benefits of This Research 
For over 35 years, the world has coped with an HIV/AIDS epidemic that has killed an 
estimated 35 million people, and at its height threatened global stability and security9. No 
longer does this disease have to devastate families, communities, and entire nations.  
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Reducing the public health threat of the HIV/AIDS epidemic by 2030 is as ambitious as it is 
possible. The promise and attainment of the 90-90-90 targets is feasible and will be another 
critical step toward ending the transmission of HIV/AIDS; ensuring PLHIV live long, healthy, 
fulfilled and quality lives; and support the eventual achievement of global HIV epidemic control.  
Understanding the factors that led to Botswana’s achievement of the 90-90-90 
targets may provide lessons and insights for countries attempting to contain and control their 
own HIV epidemics. Moreover, understanding the level of reproducibility for the factors that 
led to Botswana’s target achievement in geographies beyond Botswana is important for 
determining implementable versus non-implementable lessons.  
This project analyzes and synthesizes information from three sources: UNAIDS data; 
peer-reviewed literature; and qualitative data from key informant interviews (KIIs) held with 
subject matter experts with knowledge and visibility of Botswana’s ART program. These 
experts provided insights into interventions that facilitated and/or detracted from the 90-90-
90 achievement, HIV data collection, or some combination thereof. 
Furthermore, this study includes a framework to assess SSA country 90-90-90 target 
achievement levels and HIV epidemic control readiness; it also provides a scorecard 
depicting the factors contributing to or detracting from 90-90-90 progress and HIV epidemic 
control across all countries in SSA. This unique synthesis of existing and new information 
will provide countries interested in achieving epidemiological control of HIV/AIDS with a 
compendium of insights to diagnose, acculturate, implement, and embed effective and 
sustainable HIV programs. 
Product of This Research: An Approach Toward 90-90-90 Achievement and 
HIV Epidemic Control  
This project provides an approach for HIV program implementers (both in country 
and ex-country) and support functions interested in moving SSA countries along the 90-90-
90 achievement readiness continuum, and ultimately, toward HIV epidemic control. This 
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approach includes a framework, named the HIV Epidemic Control Readiness Framework 
(HECRF), which matches lessons learned from the Botswana HIV experience with 
quantifiable economic and social indicators on a per country basis to evaluate the 
effectiveness and sustainability of HIV programs in SSA. The HECRF provides a model for 
HIV program implementers and support functions to evaluate: 1) how their HIV prevalence 
compares to other SSA countries, 2) where they score relative to other SSA countries in 
their progress towards 90-90-90, 3) where they score relative to other SSA countries in the 
sustainability and effectiveness of their HIV programs, 4) where they score relative to other 
SSA countries in their HIV epidemic control readiness and, 5) where increased focus and/or 


















CHAPTER 2: REVIEW OF THE LITERATURE 
 The purpose of this literature review is to establish and assess the extant literature 
relevant to the 90-90-90 targets and Botswana.  
The History of HIV in Botswana 
Since the beginning of the HIV/AIDS epidemic in the late 1980s, Botswana has been 
a pioneer in HIV response due to the country’s willingness to acknowledge the problem and 
devote resources toward elimination. Botswana holds a unique position in sub-Saharan 
Africa: having experienced no major wars, it is politically stable and enjoys a constitutional 
democracy as its form of government. Additionally, born of the diamond trade and ensuing 
government management, relative to other African nations, Botswana is rich, boasting 
$17.9k Gross National Income (GNI) per capita in 2018, outpaced only by Seychelles, 
Mauritius, and Equatorial Guinea10. Within Botswana, income exceeds expenditure, and 
during the 1980s and 1990s, the government was able to build significant monetary reserves 
that were partly devoted toward the development of hospitals and clinics12. In 1995, there 
was approximately one health facility per 2,500 people12. However, despite achieving the 
world’s highest economic growth rate during the last third of the 20th century, its citizens 
regarded Botswana as a “rich country of poor people,” evidenced by the fact that 47% of the 
population lived below the poverty line in 1993-9413. Since then, the poverty rate has steadily 
declined to 19.3%, with the last available data recorded in 200914.  
Once HIV was acknowledged by the government as a problem worthy of attention, 
Botswana became a leader and first mover in its HIV response. Botswana was the first 
African country to provide free universal ART treatment15 and to launch an extensive mother-
to-child (MTC) prevention program, as early as 199912. However, despite being an early 
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adopter of HIV innovation, at 21.9%, Botswana had the third-highest HIV prevalence in the 
world as recently as 201616. 
The 1980s 
“[AIDS is] not a problem in Botswana” declared a Tswana government official 
in 1984 after over 200 blood specimens collected in the country’s north 
showed no HIV. “AIDS is primarily a disease of homosexuals and there is no 
homosexual in Botswana”13. In fact, the first case reported in Botswana was 
in a white homosexual13. One year later, when the first Tswana tested positive 
for HIV, the Ministry of Health (MOH) stated that the mode of transmission 
rendered the disease incapable of becoming a widespread epidemic. Within 
another year, the same MOH official spoke of “a scourge that could decimate 
a large portion of the human race” and recommended “a stable, faithful 
relationship with another uninfected person”13.  
The realization that HIV was a problem in Botswana came early in the southern 
Africa region – a decade before its neighbor South Africa. In 1987, the Botswana 
government called on international agencies for advice and insight, and subsequently 
outlined a one-year emergency plan followed by a series of five-year strategic plans. These 
plans included programs aimed at surveillance, education, and intervention12. At that time, 
there were 30 known HIV cases in Botswana, with estimates that the real number could be 
closer to 3,00013. 
In 1988 the first phase of HIV/AIDS policy was enacted, involving a mass education 
campaign with condom use at its center12. However, the combination of cultural mores and 
the newness of the disease left those at whom the message was targeted disbelieving its 
appeal. At this point, AIDS was dubbed the “radio disease,” “as the radio had been the prime 
and, for many, the only [source of] knowledge they had of this new threat”12. 
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The 1990s 
The AIDS epidemic in Botswana continued advancing and reached its maturity in the 
1990s. In 1990, the national prevalence in adults in Botswana hovered around 2-3%. By 
1995, this rate soared to 23%, thereby earmarking Botswana as a chief focus of the global 
epidemic13. The numbers of PLHIV in Botswana doubled in the five years after the rollout of 
the first sentinel survey indicating the presence of the disease in 1992, and by 1997, 
Botswana became known as the AIDS capital of the world12. Intensity of the Botswanan HIV 
epidemic growth may be related to the initial and primary focus on screening blood to 
eliminate the risk of transmission through transfusion15, as well as the fact that, by today's 
standards, public spending devoted to addressing HIV/AIDS was minimal and remained so 
until 1997. By the mid- to late 90s, the notion of AIDS as the “radio disease” had been 
debunked, as a significant portion of the population had direct experience of its horrors due 
to the deaths of family and friends. 
In April 1997, the mid-term transfer of power from President Masire to President 
Mogae marked a key date for change in the national HIV/AIDS policy12. In 1999, Botswana 
became the first African country to launch an extensive prevention of mother to child 
transmission (PMTCT) program13, and began laying the groundwork for encouraging testing 
and new initiatives toward the disease12. Nevertheless, the strength of the stigma pressed 
on, with only seven people having “come out” as HIV positive by 199912. 
The 2000s 
By 2000, according to UNAIDS, Botswana had the highest HIV adult prevalence rate 
in the world (36%)13. While the Botswanan HIV epidemic was reaching its height in the 
2000s, so was the national and international HIV response. The African Comprehensive 
HIV/AIDS Partnership (ACHAP), established by President Mogae, was a public-private 
sector initiative between the Government of Botswana, the MSD/Merck Company 
Foundation and the Bill and Melinda Gates Foundation12. ACHAP functioned as a major 
external donor which invested $152 million in HIV/AIDS support beginning in 200112. By 
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2004, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) had contributed more 
than $700 million to Botswana’s response to the HIV/AIDS epidemic17. Although the Merck 
and Gates investments have since ceased, ACHAP has survived by seeking other donors. In 
addition, Botswana was identified as a Global Fund Principal Recipient in 2015 and as a 
PEPFAR implementing partner for voluntary male medical circumcision (VMMC)17. Currently, 
36% of Botswana’s HIV program funding comes from international donors18. 
In 2001, President Mogae established ACHAP to not only to provide “relief to the 
afflicted and prolong life,” but to provide therapy, solidify testing protocols and reduce 
stigma12. ACHAP was responsible for financing Botswana’s Masa (or “New Dawn”), Africa’s 
first ART project13. Masa’s aim was to treat approximately 20% of the 110,000 people who 
could benefit from ART therapy (e.g. those with a CD4 cell count of 200 or less) by 200212.  
Masa was as impactful as it was challenging. The Masa program was designed for 
patients to be supported in their HIV journey. Each patient could attend specially dedicated 
operating sites and had a family member or trusted friend supervise regular drug taking. 
Unfortunately, despite having a well-developed health care sector (by SSA standards), 
Botswana lacked testing facilities and did not have adequate numbers of staff to supply ART 
on the scale required by Masa12. Thirty-two specially dedicated operating sites were planned 
to deliver therapy, but only two centers were operational by the end of 2002 and four by April 
2003. Nine months after the program began, only 1,600 people were being treated13, and 
after two years, just 4,643 people were on ART12. 
Even these low numbers nearly overwhelmed medical staff, who came to understand 
that the admission and commencement of treatment (especially for advanced cases of 
HIV/AIDS) was severely demanding of physicians’ time13. Managers of Masa learned that 
technical and administrative procedures for caring for PLHIV needed to be much more 
sophisticated and extensive in order to address mobile patients, ensure drug regimen 
adherence, and monitor viral load13. However, despite these difficulties, by September 2004, 
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Masa was treating between 36,000 and 39,000 patients, making it the most successful 
program in southern Africa13. 
In tandem with Masa, by late 2002, the PMTCT program implemented three years 
prior demonstrated a 22% reduction in transmission. Furthermore, it was estimated that 34% 
of pregnant women with HIV were receiving azidothymidine (AZT), a drug proven to reduce 
MTC transmission13.  
Unfortunately, stigma surrounding HIV remained and in 2003, despite tens of 
thousands of patients being treated13, according to ACHAP, the number of patients who had 
publicly acknowledged their HIV status to others beyond their care team had increased only 
to 1212. In June 2003, at a testing procedures seminar in Gaborone, UNAIDS coordinator 
Kwame Ampomah criticized the “current testing policy for failing the objectives of public 
health”12. “Has there been a case in history where a major public health catastrophe was 
effectively managed and brought under control by placing individual rights above collective 
rights as public interest?” Ampomah reportedly asked this question in an attempt to argue for 
the need to “normalize” HIV/AIDS12. This was the beginning of a critical revision of the ART 
program’s approach to the pandemic. In November 2003, President Mogae supported a full 
testing program, recommending it become routine (with an opt-out clause) at all government 
facilities. Thus, from January 2004 onwards, routine testing occurred in hospitals and 
throughout the public sector health provision12.  
By 2008, spending on Botswana's response to HIV/AIDS had risen to $340 million, of 
which approximately two-thirds was provided by Botswana's central government – a 
significantly higher proportion than in other SSA nations15. In 2011, on World AIDS Day, an 
innovative approach to HIV prevention education, TeachAIDS, was launched across every 
school in Botswana through a collaboration including the Ministry of Education, United 
Nations Children’s Fund (UNICEF), and Stanford University, with the aim of combatting HIV 
messaging fatigue through culturally appropriate software19. 
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The Current State of HIV in Botswana 
On June 3rd 2016, Botswana launched its “Treat All” strategy, demonstrating its 
commitment to Universal Health Coverage (UHC) and ensuring that all who test positive for 
HIV receive treatment regardless of their viral load or CD4 count20. Botswana’s commitment 
to “Treat All” came quickly on the heels of the 2015 revisions to the World Health 
Organization (WHO) ART treatment guidelines. Based on three randomized controlled trials 
including the Strategic Timing of Antiretroviral Treatment (START) study and 21 
observational studies, the revisions strongly recommended that ART should be initiated in all 
adults living with HIV, regardless of WHO clinical stage and at any CD4 cell count21.  
Despite Botswana’s 2016 “Treat All” approach, national and universal free ART for all 
PLHIV15, and achievement of the 90-90-90 viral suppression goal of >73% for all PLHIV in 
20169, Botswana remains one of the most HIV-affected countries in the world. An estimated 
370,000 PLHIV were living in Botswana in 2018 and the country had a national HIV adult 
prevalence rate of 20.3%11, revealing gaps in the Botswanan approach to HIV.  
Gaps in Botswana’s HIV response can be identified by analyzing where there are 
notable differences in prevalence rates amongst different population segments. These 
segments, known as “key populations,” generally have the highest risk for becoming infected 
with and transmitting the disease, and in addition, are the most underserved in the HIV 
response; these populations may account for the majority of PLHIV who are not virally 
suppressed. 
In 2016, adult women (age 15-49) were (and remain, as of 2018) disproportionately 
affected, with a prevalence rate of 26.3%, compared to 17.6% for men in the same age 
group15. Additionally, young people (age 15-24 years old) represented 20% of Botswana’s 
HIV-affected population. HIV prevalence has improved little over the past decade; 
specifically, 2005 saw a 6% prevalence in young people, compared to 5.4% among young 
men and 10.2% among young women in 201615. While prevalence rates in young people are 
low in comparison to other key populations, focus on this demographic is important because 
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in SSA, young women accounted for 25% of new HIV infections in 2015 and because it’s 
most effective to change behavior before sexual debut22. Female sex workers also showed 
a disproportionate HIV prevalence rate in comparison with the total population; the extant 
data on female sex workers is based on a 2012 study in three districts (Francistown, 
Gaborone and Kasane) that found a 61.9% HIV prevalence amongst the 4,000 female sex 
workers surveyed15. Men who have sex with men (MSM) are another key population with 
disproportionate prevalence rates, which may be attributed to homosexuality being illegal in 
Botswana until 2019 and driving minimal disclosure of same-sex acts as the mode of HIV 
transmission. As with female sex workers, the latest data is based on a 2012 study in three 
districts (Francistown, Gaborone and Kasane), which estimated HIV prevalence at 13.1% 
amongst MSM. In 2014, Botswana’s Supreme Court ruled that all HIV-positive prisoners 
(regardless of nationality) must be provided free access to ART15, indicating that this group 
may also be disproportionately affected by HIV.  
Successful epidemic control requires stopping HIV transmission, which can be 
achieved through viral load suppression. This means that epidemic control is jeopardized by 
the percentage of PLHIV who are not on ART and the percentage of PLHIV who do not have 
suppressed viral loads; in 2018, 83% and 81% of Botswana’s PLHIV were on ART and 
virally suppressed, respectively11. Given the increased risk of key populations to become 
infected with and transmit HIV, a lack of targeted services for these populations translates 
into prevention programs reaching less than half of those at risk15. 
As of 2016, no specific strategy existed to reach the 55.1% of key populations who 
are not currently being attended to by government programs15. However, Botswana’s 2016 
National Strategic Framework for HIV and AIDS references “all-inclusive programming,” 
which may support female sex workers, MSM, young people with HIV and women with HIV – 
all of whom are part (but not the entirety) of key populations most affected by HIV15. For the 
first time, in 2012, government supported a concentrated effort to better understand female 
sex workers and MSM by including these groups in HIV epidemic surveys15. Unfortunately, 
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legal and punitive barriers for key populations challenge and may undermine the advanced 
and rigorous HIV prevention and support efforts undertaken in Botswana15. However, 
Botswana continues its progress – on June 12th 2019, the Gaborone High Court reversed 
colonial era laws and decriminalized consensual same-sex relationships. 
Importance and Rationale 
 
Figure 4: Photograph of David Kirby taken by Therese Frare 
In November 1990, LIFE magazine published the photograph of David Kirby (Figure 4, 
taken by Therese Frare): a young man, surrounded by his pained and loving family, as he 
lay dying from AIDS.  
“…His nose swelled up and developed painful blisters from sporotrichosis, a 
disease that normally afflicts miners and spelunkers exposed to bat dung. Edema 
had swelled his ankles so badly that every step became a painful journey. Weight 
loss (in Africa, AIDS is known as the Wasting Disease) eroded any protection of 
fat or muscle so that a pebble felt like a bullet fired into his skin. Constant coughs 
wracked his body, and every breath sapped him of his last reserves of strength. 
Eczema made his skin feel like burning coals. His throat had become so infected 
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with Kaposi’s sarcoma, swollen lymph glands, and other infections that every 
swallow became a horrific struggle… Every orifice oozed fluids: nosebleeds, 
night sweats, incontinence and diarrhea, runny eyes, bursting pustules, bleeding 
gums. His ears, hair, nails, teeth—every organ rebelled. Worse than the physical 
misery was the self-consciousness of people’s revulsion. Always meticulous 
about his appearance, he had trouble shaving because of lesions and swelling 
and became unable to bathe himself. Clothes hung limp on his tiny, emaciated 
frame… It was obvious to everyone who saw the corpse that this was a man 
who... was already in the terminal stages of his illness23.” – Stephen Weinstein’s 
account of losing his partner, Tom, on May 15th, 2001, to AIDS. 
For more than 35 years, the world has faced an HIV/AIDS epidemic that has killed an 
estimated 35 million people, devastated families and communities, and stigmatized, 
marginalized, and ostracized those most in need of care. No longer does this disease have 
to ruin lives, ravage families, nor destroy communities, and entire nations.  
Breakthroughs in HIV/AIDS treatment, including the development of the first ART 
(azidothymidine) and the introduction of highly active antiretroviral therapy (HAART) in 1996, 
have dramatically reduced HIV mortality and morbidity. These treatment changes have 
shifted HIV prognosis from an almost certain death sentence to being manageable as a 
chronic disease and brought hope to those suffering from the disease. In 2000, the 
Millennium Development Goals lay the foundation to bring the HIV/AIDS epidemic under 
control. Between then and 2015, two Security Council resolutions and three subsequent 
United Nations Political Declarations galvanized action by focusing on setting increasingly 
ambitious targets. In 2011, global leaders called for the goal of providing 15 million people 
with life-saving HIV treatment by 2015 – and the world responded, ahead of schedule24. If 
we had stayed unmoved and complacent, “30 more million people would have been infected 
with HIV, 7.8 million more would have died and 8.9 million more children would have been 
orphaned due to AIDS.24” 
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While incredible progress has been made regarding HIV treatment (for example, pre-
exposure prophylaxis (PrEP), single-tablet regimens (STR’s), two-drug regimens, and long-
acting ART compounds), the emergence of HIV drug resistance has created the need for 
robust HIV testing and treatment programs. However, despite drug resistance setbacks, the 
world has seen substantial advancement in how HIV is treated and prevented. For example, 
the U = U (Undetectable = Untransmittable) movement – meaning that someone on ART 
with an undetectable HIV viral load cannot sexually transmit HIV, even without using 
condoms or PrEP – has been endorsed by (including, but not limited to) the U.S. Centers for 
Disease Control (CDC), the Government of the United Kingdom, the International AIDS 
Society (IAS), and UNAIDS. The evidence supporting U = U encompasses different types of 
research spanning observational studies, randomized trials, systematic reviews and expert 
opinion. Most recently, in June 2019, the Lancet published PARTNER 2 study results 
reporting zero linked HIV transmissions from nearly 1,000 gay couples who had sex more 
than 77,000 times without condoms25. U = U applies to virus transmission from an HIV-
infected person to a non-infected sexual partner, regardless of the type of sex (i.e. oral, 
vaginal, or anal). 
Further reducing the public health threat of the HIV/AIDS epidemic by 2030 is 
challenging, yet possible. Global 90-90-90 attainment would be another step toward global 
viral suppression, ending the transmission of HIV/AIDS, and eventually achieving complete 
epidemic control. As it is one of the first seven countries in the world, and the first country in 
SSA, to exceed the 90-90-90 viral suppression goal of 73% within the total HIV population, 
analysis of how Botswana achieved this milestone may support other countries in learning 
and adopting strategies to catalyze their own 90-90-90 target achievement, and thereby 
move toward controlling the HIV epidemic on a global scale. 
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Literature Review Methods 
A systematic, broad, and exhaustive search was conducted using the following 
databases: PubMed, Embase, Scopus, Web of Science, Proquest, Ebscohost, and the 
African Online Journal. Of particular note, all 60 databases within Proquest were searched 
alongside all Ebscohost databases, and 29 studies and reports were identified (see Table 2: 
Database Search Strategy Results). The total number of identified database search records 
was reduced after the removal of duplicate records.  
Table 2: Database Search Strategy Results 
 
Search Terms 
The search strategy employed terms appearing in Table 3: Search Terms. Searches 
were limited to English with a date restriction of publications inclusive of and after 2015 (due 
to the fact that the 90-90-90 goals were adopted in 2015) however, articles identified due to 
snowballing were not excluded based solely on date of publication. A broad search strategy 
was employed, examining all articles with variations on the terms “90-90-90,” “HIV” or 
“AIDS,” and “Botswana” in the title, abstract, and key words, to identify and optimize search 
results for examination. 
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Table 3: Search Terms 
 
 
Inclusion criteria were: 
• Full text available 
• Qualitative and quantitative studies 
• Descriptive and analytical studies 
• Published in English  
• Research conducted outside the United States 
Exclusion criteria included:   
• Studies not published in English 
• Articles assessing regions and countries beyond Botswana 
• Articles focused on mental health counseling in relation to HIV 
• Studies assessing primary endpoints related to HIV co-infections and/or diseases (e.g. 
TB, depression) 
• Supply chain assessment 
• Drug resistance assessment 
• Studies focused on the optimization of drug treatment regimens 
• Therapeutic advancements 
• Original articles followed with corrections (only corrected articles were used) 
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• Clinical drug trials 
• Papers for licensing drugs 
• Paper submission announcements 
• Conference proceedings (without full study documentation) 
Review of the articles’ titles and abstracts initiated the process of determining potential 
study insight into what can be learned from Botswana’s experience with HIV, the country’s 
achievement of the 90-90-90 targets, and how lessons learned and best practices can be 
adapted and applied. The number of screened records was further reduced by implementing 
the above-mentioned exclusion criteria and by assessing full-text articles for eligibility. The 
principle investigator (PI) quantified and explained the exclusion of full-text articles in the 
results section. 
Results 
The results of the database search are detailed in Table 2: Database Search 
Strategy Results. The database search yielded 29 total records, including two from PubMed, 
13 from Embase, four from Scopus, two from Web of Science, six from Proquest, one from 
Escohost, and one from the African Online Journal. Full text was inaccessible for 10 of these 
articles, with the majority of the inaccessible articles (n = 8) being linked to the Botswana 
Combination Prevention Project (BCPP), a joint effort between the Botswana Ministry of 
Health, the Harvard T.H. Chan School of Public Health AIDS Initiative (HAI), the Botswana 
Harvard AIDS Institute Partnership (BHP), and the U.S. Centers for Disease Control and 
Prevention (CDC)26. A total of 10 duplicate records were identified and removed, leaving 
nine records for title and abstract review. During the initial title and abstract review, three 
records were eliminated, leaving six records for full-text review. All three articles excluded 
during the title and abstract review concentrated on regions and countries beyond Botswana 
(Switzerland, South Africa, and non-specific geography). A bibliographic search strategy was 
employed to identify additional relevant studies (snowballing) cited in the six full-text articles. 
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To inform this systematic review, four additional articles were included based on 
snowballing, leaving a total of 10 relevant articles. Results of the database search are 
visually represented in Figure 5: Prisma Diagram. 
 
Figure 5: Prisma Diagram 
The assessment of factors driving Botswana’s 90-90-90 achievement varied based 
on the lens and design of the study or article reviewed. Six themes contributing to 
Botswana’s encouraging HIV outcomes were identified through the literature review. These 
are described, alongside sub-themes, in Table 4: Literature Review Themes and Sub-
Themes. The themes included: 1) Expanded ART Coverage (also explored as test-and-treat, 
program scale-up, and free universal coverage), cited in four out of 10 of the full-text articles 
reviewed; 2) Prevention Programs and Behavior Change, cited in four out of 10 reviewed 
articles; 3) Development of Health Infrastructure, cited in two out of 10 reviewed articles; 4) 
Partnerships and Funding, cited in four out of 10 reviewed articles; 5) Economic and Social 
Stability, cited in two out of 10 reviewed articles; and 6) Care Innovation, cited in eight out of 
10 of the articles reviewed.  
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Themes contributing to Botswana’s 90-90-90 success that could be expanded into 
sub-themes (also detailed in Table 4: Literature Review Themes and Sub-Themes) included 
prevention programs and behavior change, with sub-themes represented by expanding 
programs for at-risk groups, community-based approaches to HIV, and decreasing stigma; 
development of health infrastructure, with sub-themes including monitoring and evaluation, 
electronic patient tracking, and the training of health care workers; and care innovation, with 
sub-themes explained in detail below. 
Care innovation was the most complex thematic category and was cited in eight out 
of 10 full-text articles as a primary driver of improvements in the HIV treatment cascade. To 
simplify the complexity within the care innovation theme, six sub-themes were identified to 
define the theme category: 1) decentralized HIV care, including the home-based care 
approach and linkage to care (cited in three articles); 2) nurse-led prescribing (cited in one 
article); 3) routine HIV testing and counselling opt-out (cited in one article); 4) male 
circumcision (cited in three articles); 5) changing/bringing the guidelines up to date (cited in 
one article); and 6) viral load and drug-resistance testing (cited in three articles). Two articles 
within the theme of care innovation focused exclusively on the viral load testing and VMMC 
sub-themes, respectively. Both viral load testing and VMMC were acknowledged in other 
articles as contributing to Botswana’s attainment of the 90-90-90 targets. Viral load testing 
and VMMC were the only thematically singular focused articles within the literature review; 
all other articles/studies addressed more than one theme or sub-theme contributing to 
Botswana’s 90-90-90 attainment.  
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Table 4: Literature Review Themes and Sub-Themes 
 
Expanded ART Coverage 
The “Expansion of ART Coverage” category encompasses both test-and-treat and 
program scale-up. Five of the 10 articles examined contained some combination of the UN 
90-90-90 goals and Botswana’s focus on expanded ART coverage in their assessment of 
HIV. Two studies used population-level data to evaluate the impact of expanded ART 
coverage, with the Gaolathe study including the data analysis accepted by the UN 
demonstrating Botswana’s achievement of the 73% viral suppression goal and aim of the 90-
90-90 targets. 
One study conducted by Farahani and colleagues examined the effect of the 
implementation of Masa, Botswana’s national ART program, on mortality by analyzing a 
dataset from the clinical information system developed by the Botswana Ministry of Health27. 
This study evaluated more than 100,000 adult patients using available electronic records 
from 2002 (the year the Masa program began) through April 30, 2010. Farahani et al, found 
that the rapid programmatic scale-up decreased mortality from 12.8 deaths per 100 person-
years within three months of treatment initiation to 1.16 deaths per 100 person-years after 
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one year of ART, and that the reduction in mortality was sustained across the subsequent 
seven years of follow-up27. Universal free testing, counseling, and treatment in Botswana 
were the major factors cited by Farahani et al. as contributing to the success of the rapid 
expansion of Masa and its favorable clinical outcomes27. 
Using the most complete population-level estimates available from the region 
(developed from the BCPP, also known as the Ya Tsie study, and designed to test whether a 
combination of prevention interventions reduces cumulative population-level three-year HIV 
incidence28), Gaolathe et al. cited universal testing of pregnant women and access to free 
ART for patients presenting with CD4 count of 350 cells per µL or less as factors contributing 
to the high rates of 90-90-90 achievement28. Of note, the Botswana MOH further expanded 
ART coverage following the 2015 WHO guidelines recommendation for ART for all PLHIV 
regardless of CD4 count. 
Drawing from ART coverage and viral load suppression data published by Gaolathe, 
Williams et al. developed a model to estimate the impact of treatment and prevention on 
infections averted, lives saved, and total costs over the period 2016 to 205029. The model is 
a standard susceptible-infected (SI) model (the simplest form of disease models where 
individuals are born into the simulation with no immunity (susceptible), and once infected 
and with no treatment, stay infected and infectious throughout their life, while remaining in 
contact with the susceptible population) fitted to trend data on the prevalence of HIV and the 
coverage of ART allowing for heterogeneity in the risk of infection29. The model suggested 
that by expanding treatment between 2016 and 2030, the Botswana HIV program would 
reduce total programmatic costs by $26 million, while averting 92,000 new infections and 
40,000 AIDS-related deaths29. 
Using a SI dynamic model to fit time trends with the prevalence of HIV, B.G. Williams 
examined historical tendencies and forecasted future HIV/AIDS prevalence/incidence of 
HIV/AIDS-related mortality, as well as the impact of starting ART across nine countries 
(including Botswana) in Southern Africa30. The study found that the scale-up of ART and 
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PMTCT programs, as well as the expansion of programs for high-risk groups (e.g. young 
women, sex workers, intravenous drug users, and MSM) led to a substantial decline in the 
number of new HIV infections and AIDS-related deaths in all countries30. 
In a perspective article, Iwuji and Newell cited the need for further scale-up of ART 
for all adults living with HIV. Furthermore, Iwuji and Newell found that programmatic scaling 
in sub-Saharan African adults in need of ART was partially responsible for successfully 
addressing of the middle-90 challenge (the percentage of patients following treatment) in the 
UNAIDS 90–90–90 targets31. Moreover, Iwuji and Newell suggested that early linkage to 
ART care is the main hurdle in the HIV treatment cascade31. 
Prevention Programs and Behavior Change 
The UN HIV investment approach includes and highlights social and behavior 
change (SBC) programs as an essential component of HIV prevention32. Although SBC is 
considered difficult to evaluate through randomized controlled trials (RCT), evidence 
suggests that SBC programs can be effective if well designed and implemented32. 
Four of the 10 articles in the literature review cited prevention programs and behavior 
change as contributing factors to Botswana’s 90-90-90 achievement. Specifically, one article 
assessed expanded programs for at-risk groups (including women, sex workers, and drug 
users), one article assessed community-based approaches to HIV, and two articles 
discussed decreasing stigma. 
In one of the more rigorous SI model analyses, B.G. Williams et al. noted that 
changes in disease transmission result from changes in behavior and prevention 
interventions, such as PrEP or VMMC30. Researchers hypothesized that patterns of 
partnership formation, resulting in fewer sexual partners, may have led to the substantial 
decline in HIV incidence and prevalence in Botswana30. Moreover, the authors observed that 
small changes in individual behavior may have collectively reduced aggregate sexual 
behavior sufficiently to disrupt sexual networks, and hence, transmission. 
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As noted in the “Expanded ART Coverage” theme, B.G. Williams et al. credited the 
scale-up of ART and PMTCT programs with leading to a substantial decline in the number of 
new HIV infections and AIDS-related deaths in all countries, including Botswana30. Further, 
the authors stated that HIV transmission and incidence will continue to be reduced with 
expansion of prevention programs focusing on high-risk groups, including the ability for 
young women and sex workers to access PrEP, intravenous drug users’ ability to access 
clean needles and safe injecting sites, young men being offered VMMC, and sex workers 
and MSM finding the agency and ability to consistently use condoms during sex. 
Sheila Tlou, the director of the UNAIDS regional support team for Eastern and 
Southern Africa, associate professor of nursing at the University of Botswana, and previous 
health minister of Botswana, has credited a community-based HIV approach for Botswana’s 
HIV success33. Specifically, HIV behavior change in Botswana is reinforced by HIV 
education of school-aged children through theater sketches, nurse-based prescriptions of 
ART, and home-based care programs supported and financed by the community33. Further, 
an innovative community-driven testing approach, which included the counseling and offer of 
HIV testing by a person living with HIV, was initially considered “home grown” in Botswana 
and inapplicable to the rest of the world33. However, at the International AIDS Society 
Conference (IASC) in Toronto in 2006, the method won international acclaim and WHO 
ultimately used the pioneering approach to develop guidelines on provider-initiated HIV 
testing and counselling in health facilities33.  
Both Farahani et al. and Gaolathe associated stigma and discrimination (Farahani. 
through the evaluation of Botswana’s Masa program and Gaolathe using the most complete, 
population-level estimates available from the region) as deterrents for PLHIV regarding 
testing for HIV and access to care27. Farahani et al. concluded that stigma reduction in 
Botswana encourages earlier HIV treatment27, and thus, decreases HIV transmission. 
Gaolathe cited the strong political will to speak openly about HIV in public forums and the 
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destigmatization of HIV testing as factors contributing to Botswana’s HIV treatment cascade 
and achievement of the 90-90-90 targets. 
Development of Health Infrastructure 
Increases in resources devoted to HIV/AIDS translate into increases in overall health 
care infrastructure, resulting in an indirect and cumulative effect for improvement of other 
disease states, primary health services, and overall health outcomes34. As a consequence of 
AIDS funding, health systems are being strengthened at the primary health care and 
community level, leading to health outcome gains in HIV/AIDS, Tuberculosis and Malaria34. 
 Of the 10 articles assessed for this literature review, two cited the 
development of health care infrastructure as affecting the length or quality of life of PLHIV. 
Both Fleck and Farahani et al. credited the training of health care workers for the substantial 
progress in the development of health infrastructure to treat large numbers of PLHIV across 
Botswana. Fleck attributed the training of skilled nurses, as discussed in the Prevention 
Program and Behavior Change section, for health infrastructure gains, while Farahani 
described international donor organizations (including PEPFAR and ACHAP) support as 
fundamental for the rapid implementation and maintenance of the training and information 
systems required to treat HIV in Botswana.  
 Furthermore, Farahani suggested monitoring and evaluation, as well as electronic 
patient tracking, as fundamental drivers in the uptake of HIV infrastructure, resulting in the 
positive outcomes for the Botswana National HIV/AIDS Program (NAP)27. According to 
Farahani, partnership between the Government of Botswana and PEPFAR laid the 
infrastructure foundation to both track patients eligible for ART and monitor the progress and 
effectiveness of the Masa program27. Moreover, the establishment of a monitoring and 
evaluation unit within the NAP provided an electronic patient tracking and outcomes 
monitoring system, which has been considered crucial in the effective scale-up of the 
Botswanan HIV program. Electronic patient tracking and outcomes monitoring enable the 
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capture of individual patient data and the generation of facility-level reports that support both 
clinic management and care of patients27. 
Partnerships and Funding 
The Botswana government engaged in partnerships in an effort to help alleviate the 
shortage of public sector medical doctors by enabling private physicians to share the patient 
burden27. Currently, physicians receive incentives to act as agents of Masa by providing 
publicly funded services that are often born of funding from partners27. As discussed in The 
History of HIV in Botswana section of this paper, Botswana engaged in partnerships early in 
the epidemic. These partnerships brought different perspectives and expertise to address 
Botswana’s HIV problem, and have since expanded from public partnerships to public-
private partnerships. 
Partnerships and funding were intended to catalyze and provide momentum to 
programs targeting prevention and behavior change. In her interview with Sheila Tlou, Fleck 
reported on the training course, KITSO – a word meaning knowledge in Setswana, and an 
acronym that stood for Knowledge, Innovation and Training Shall Overcome AIDS33 – which 
was born out of the partnership between university teachers, the MOH, HAI, and other 
partners and civil society. The KITSO program has successfully trained health care 
providers, including nurses, to prescribe ART. According to the interview, within four years, 
90% of PLHIV coming through the program were on ART with arranged follow-up33.   
As discussed in the section “Development of Healthcare Infrastructure,” Farhani cited 
PEPFAR funding and partnership with ACHAP for catalyzing capacity building for HIV care 
infrastructure and the ability to monitor and evaluate PLHIV. Specifically, the financial 
resources made available by PEPFAR, ACHAP, and other international donors have 
supported swift implementation and maintenance of training on information systems required 
for the care of PLHIV in Botswana27. In practice, ACHAP partnerships and funding resulted 
in the ability of the Botswana MOH KITSO program to train 9,000 healthcare workers in 
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201227. Moreover, the PEPFAR Clinical Master Training Program has ensured health care 
professionals receive HIV/AIDS-related technical support and stay up to date on 
advancements in care to ensure motivation and continued dedication to bringing HIV under 
control27. In addition, these partnerships have been responsible for innovative testing 
techniques discussed in the “Prevention and Behavior Change” theme, where de-
stigmatization and relatability between those infected with HIV was encouraged through the 
offering of HIV testing and counseling by a PLHIV33. 
Highlighting the contribution of successful public-private partnerships designed to 
combat the HIV/AIDS epidemic in Botswana, Debswana, a 50/50 partnership between the 
De Beers Group (a diamond mining company) and the Botswanan government, have made 
addressing HIV a central pillar of their business design35. Debswana’s efforts to control HIV 
in Botswana have included providing testing and education programs for their employees 
and families, and opening hospitals at mines, which were originally intended for employees 
but now function as free referrals and treatment centers for the general public36. Debswana’s 
efforts have been in concert with those of the Botswana government36 and have paved the 
way for other private employers to adopt similar practices36. For example, Anglo American, 
another mining group and one of Africa’s largest private employers, began an HIV treatment 
program for its workers in 2002, and, by 2007, had over 11,000 employees living with HIV 
enrolled, with ~4600 receiving ART treatment36. 
Care Innovation 
The nature and history of HIV/AIDS makes care innovation the central pillar to 
achieving 90-90-90 and living with HIV more tolerable until a cure is found. As such, care 
innovation is a complicated theme that supports, bridges, and synergizes the 
interdependencies amongst the other themes discussed. Sub-themes within care innovation 
are categorized and discussed in the following sections. Treatment innovation, such as 
PrEP, STR’s, two-drug regimens, and long-acting ART compounds, have been excluded 
from this analysis to avoid any conflict of interest, because the principal investigator (PI) of 
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this study works for a drug company dedicated to HIV prevention, treatment, and cure 
research, with drug innovation at the core of its business model. 
Nurse-led prescribing  
Botswana’s first medical school was established in 200937. Until then, there were no, 
or very few, medical doctors. The shortage of physicians meant nurses were always on the 
front lines of medical care, and the situation during the early stages of the HIV epidemic 
proved no different33. Health care facilities in Botswana have always been staffed by nurses; 
therefore, in addition to nurse-led ART prescriptions supporting the expansion of 
environments where PLHIV could receive care (doctors were only available to be seen at 
hospitals), nurse-led ART prescriptions more closely mirrored the health care procedure 
Botswanan’s were accustomed to33. 
Routine Opt-out Procedure for HIV Tests and Counselling  
Before 2004, Botswana offered “opt-in” HIV tests13. This practice necessitated 
patients to specifically ask to be tested for HIV. The move to “opt-out” of testing and 
counseling in health-care settings, initiated by former Botswana President Festus Mogae28, 
meant that instead of a patient request triggering an HIV test, all patients were offered an 
HIV test that they could “opt-out” of, or decline to take. The “opt-out” practice may have been 
responsible for more robust diffusion of HIV testing than if health care providers waited for 
patients to ask for an HIV test. 
Decentralization of HIV Care  
Since the onset of the HIV/AIDS epidemic, urbanization has been steadily causing a 
decline in the size of Botswana’s rural population. However, the World Bank (WB) estimated 
that, in 2018, 30.6% of Botswana’s population remained concentrated in rural areas38. With a 
widely dispersed population, decentralized HIV treatment has meant that patients could be 
seen throughout the country. Specifically, ART is available from more than 600 clinics 
nationwide, alongside other health services28. As discussed in the “nurse-led prescribing” 
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section of this paper, the ability of nurses to provide ART prescriptions and care has been 
largely responsible for patients’ ability to be seen outside of hospitals33, which are 
concentrated in cities. The proliferation of clinics throughout Botswana has expanded the 
linkage of HIV care28 and meant shorter traveling distances are required for patients to 
receive care. Moreover, distance to services is correlated with retention in care28 and an 
estimated 95% of Botswana’s population resides within 10 km of an ART-dispensing facility, 
which translates into a greater ability to retain PLHIV in care28, which is critical to advancing 
and maintaining high numbers in the testing and treatment cascade. 
A home-based care approach, whereby nurses would travel to the homes of patients 
instead of requiring patients to come into a clinic, was developed out of a grassroots initiative 
in response to what women said they needed at home33. A home-based care pilot program 
was developed together with the Society for Women and AIDS in Africa Conference in 
Botswana (SWAABO) and the Botswanan government, based on the success of a program 
started by a community in northern Botswana33. The program encompassed everything from 
supporting women by working with SWAABO to role play negotiating safer sex with their 
husbands33, and engaging lawyers to help people make living wills28. 
Studies have suggested that once people engage in ART care, they are likely to 
adhere to the regimen, at least in the short term, and that early linkage to HIV care is the 
main hurdle in the testing and treatment cascade31. Moreover, high acceptability of home-
based HIV testing, and a less-than-optimal linkage to centralized care, combined with the 
rate by which PLHIV initiate ART31, may provide evidence that the decentralization of HIV 
care, and specifically, home-based care, may be responsible for the uptake of ART in 
Botswana and ensuing high viral suppression rates within the HIV population.  
Male Circumcision  
In March 2007, the WHO and UNAIDS recommended male circumcision (MC) as an 
additional method of HIV prevention39. Moreover, countries with low MC prevalence and 
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generalized HIV epidemics were encouraged to rapidly scale-up VMMC programs in the 
context of combination prevention39. Acting on this recommendation, in partnership with the 
BCPP, Botswana set up programs that offered VMMC to males requesting the procedure 28.  
Williams, Gaolathe and Kripke, in three different papers, have all asserted that MC is 
an HIV care innovation responsible for changes in HIV transmission. The discussion section 
of Williams’ Epidemiological Trends for HIV in Southern Africa: Implications for Reaching the 
Elimination Targets concluded that VMMC must be expanded in order to achieve the 
elimination targets required by 90-90-9030, while Gaolathe et al. used data from the BCPP to 
analyze the impact of a combination prevention package, including MC, to assess 
Botswana’s progress toward 90-90-9028. Gaolathe et al. concluded that, among the 12,610 
participants surveyed in the BCPP, 3,596 (29%) were living with HIV, and 2,995 (83.3%) of 
these individuals already knew their HIV status (representative of the first 90). Among those 
who knew their HIV status, 2,617 (87·4%) were receiving ART (representing the second 90), 
and of the 2,609 individuals receiving ART with a viral load measurement, 2,517 (96·5%) 
had a viral load of 400 copies per mL or less28. According to Gaolathe et al., overall, 70.2% 
of PLHIV had virological suppression (representing the third 90), close to the UNAIDS target 
of 73%28.  
Kripke et al. assessed the age-specific impact, cost-effectiveness, and coverage 
attributable to circumcisions performed through 2014, and compared the impact of actual 
progress to that of a model demonstrating achievement of 80% MC coverage among men 
aged 15-49 in 12 VMMC priority countries, including Botswana39. According to Kripke et al, 
circumcision coverage more than doubled among men aged 15-49 years in Botswana39, and 
coverage among males progressed from a baseline MC prevalence of 4% to an estimated 
63% among those aged 10-14, and from 6% to 40% among those aged 15-19 by the end of 
201439. The study concluded that VMMC remains an impactful and cost-effective 
intervention to decrease HIV incidence39 and thereby drives toward the aims of 90-90-90 by 
reducing the risk of heterosexually acquired HIV infection. 
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Bringing Guidelines Up to Date  
The optimal point to start antiretroviral treatment for HIV has been debated amongst 
scientists since 198740. Positions have varied between delaying treatment until specific 
points in disease progression (e.g. at certain CD4 cell count thresholds, representing the 
level of virus in the body) and treating people with HIV as soon as they are diagnosed40. 
The Botswana national guidelines have adapted since the start of the Masa program 
in 2002, to account for improved understanding of the HIV lifecycle, reduce adverse events 
associated with early ART, and accommodate the availability of improved treatment 
regimens27. Eligibility criteria for receiving ART changed in 2008, from presenting with a CD4 
cell count of 200 cells/µL to 250 cells/µL and, in 2013, to 350 cells/µL27. In 2016, aligned with 
WHO treatment guidelines, Botswana launched a “Treat All” strategy, with the aim of starting 
anyone who tests positive for HIV on treatment immediately, regardless of their CD4 count. 
Viral Load and Drug Resistance Testing  
Since the inception of Botswana’s HIV program, virological monitoring has enabled 
the assessment of treatment and interventions for patients28. This early adoption of care 
innovation has supported the detection of early signs of treatment adherence problems 
before immunological decline41. Furthermore, virologic information can be critical for 
informing adherence interventions and timely switching to second-line drug regimens, before 
drug resistance develops41. While Botswana has been a first mover in viral load and drug 
resistance surveillance, many countries are not as advanced in their HIV response41. Studies 
by Peter et al. and Williams et al. both concluded that viral load and drug resistance testing 
are essential for achieving treatment targets, and require increased resource and investment 
in human, technical, and financial systems30. 
Economic and Social Stability 
According to 2019 WB classifications, Botswana is an UMIC42 and is considered one 
of Africa's most stable countries, boasting a relatively corruption-free environment with a 
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good human rights record43. Botswana’s stable democracy, small population of 
approximately two million people, and high per capita gross domestic product (GDP)44 may 
all be factors in its the ability to concentrate effort and resources on addressing the country’s 
HIV epidemic. 
Wilson argued that Botswana’s comparative success in the fight against HIV was 
born from diamonds – the same natural resource that underpins the country’s economic and 
social stability36. Debswana, also discussed in the “Partnership and Funding” section of this 
paper, contributes approximately 50% of public revenue and 33% of GDP36. Debswana’s 
website boasts its commitment to its people and community as that dedication relates to 
HIV: “In 2001, Debswana was the first company in the world to offer free antiretroviral 
therapy to any infected employee and their spouse. There has been a significant evolution 
and advancement in the HIV/AIDS program to a point where employees, their legally married 
spouses and up to three children under the age of 21 receive 100% subsidy from the 
company for the cost of antiretroviral therapy, prophylactic and opportunistic infections 
treatment and related monitoring tests.” Furthermore, Debswana claims it was the first 
company in the world to deliver ART to its employees35. 
Discussion 
Since the 2014 launch of the 90-90-90 targets at the 20th IASC in Melbourne, 
Australia, the global quest to bring the HIV/AIDS epidemic under control has been propelled 
by the goal of attaining epidemiological control of the disease. The 90-90-90 targets reflect a 
paramount shift in the world’s approach to HIV treatment, moving away from a focus on the 
number of people accessing ART and toward the prioritization of maximizing viral 
suppression amongst PLHIV. The catalyst for this move was greater understanding of the 
benefits of viral suppression – not only does treatment protect PLHIV from AIDS-related 
illness and reduces morbidity, it also greatly lowers the risk of transmitting the virus to 
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others. Based on this understanding, it is now widely accepted that undetectable viral loads 
mean untransmittable virus, or “U = U”45. 
The full-text articles included in this review were an equal mix of quantitative and 
qualitative evaluations. The most rigorous study design was a mixed-methods randomized 
control trial: 90-90-90 Antiretroviral Therapy and Virological Suppression Goals: A 
Population-Based Survey, published by Gaolathe. A random sample of approximately 20% 
of households in 30 communities across Botswana was evaluated using blood tests and 
questionnaires, in order to assess the country’s progress toward 90-90-90. The data have 
been acknowledged as among the most complete, population-level estimates available from 
the region, and show very high rates of coverage related to HIV testing, ART initiation, and 
viral suppression. This study demonstrates high levels of validity and reliability, in that both 
the measurement of HIV within the Botswanan community and the overall results were 
accepted by the UN as the basis for the global acknowledgement that Botswana has 
achieved the 90-90-90 viral suppression goal. 
While the six themes identified in this literature review aimed to identify and inform 
the best practices responsible for Botswana achieving the 90-90-90 targets, each theme has 
been explored independently. Further discovery of the interdependencies and synergies 
between the themes could help catalyze and optimize future gains in the HIV viral 
suppression landscape. For example, expanded ART coverage and the development of 
health infrastructure are reliant on partnerships and funding, which may have been a 
consequence of the economic and social stability enjoyed by Botswana. Prevention 
programs and behavior change are underpinned by care innovation, and care innovation is 
mobilized by partnerships and funding. Given the effect each of the themes may have on 
another, greater clarity into the optimal combination of thematic integration may be 
warranted. Additionally, evaluating the unique characteristics of Botswana that may not be 
replicable across countries with a substantial HIV disease burden is worthwhile, as 
understanding which practices and lessons that are replicable and can be adopted 
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elsewhere may truncate the lead time required to achieve the 90-90-90 targets on a 
worldwide scale.   
Limitations 
Several limitations exist in this literature review. First, while seven databases were 
searched, including all 60 databases within Proquest and all Ebscohost databases, any 
relevant studies, and specifically, grey literature, that were not contained within the search 
strategy were not reviewed. Second, the systematic integrity of the review could be called 
into question as the full text was inaccessible for 10 articles. The majority of the inaccessible 
articles (n = 8) were linked to the BCPP, which may have provided additional insight and/or 
reinforced the themes identified in the review of literature. Third, the researcher exercised 
judgment to inform which studies contributed to answering the question of interest and were 
therefore included in the review. Fourth, the broad choice of search terms may have led to 
the identification of fewer studies specifically related to how Botswana achieved the 90-90-
90 goals, which may result in the appearance of a wider gap in the literature than actually 
exists. Fifth, and perhaps most importantly, treatment innovation, which is largely 
responsible for increased efficacy and tolerability, and therefore has an inextricable link to 
viral suppression rates, was not included in this review to avoid a conflict of interest by the 
PI. Finally, the quality of the external validity of the studies was strong in terms of the 
relevance and applicability of this systematic review; however, the internal validity of the 
studies assessed could be questionable, as many (n = 5) were meta-analyses or systematic 
reviews with a qualitative bent that drew conclusions without a quantitative study design. 
While this literature review does not unequivocally answer the question of how 
Botswana achieved the 90-90-90 targets, it provides an appreciation of Botswana’s 
response to the HIV epidemic and a framework for best practices that may be at least 
partially responsible for the country’s monumental achievement. Therefore, continued 
assessment of the factors compelling Botswana’s 90-90-90 achievement amongst all PLHIV 
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is warranted, in order to recognize, highlight, and adapt lessons that will support other SSA 





CHAPTER 3: RESEARCH DESIGN AND METHODOLOGY 
Conceptual Framework 
Ending HIV by 2030, and the attainment of 90-90-90 by 2020, requires “countries to 
recalibrate their program design to make their responses flexible, suited to subnational 
epidemiological realities, and responsive to the needs of PLHIV and populations left 
behind24.” Conceptual models relating to HIV/AIDS span the disease continuum and include 
health systems management, structural drivers, pathways for care delivery, analysis of 
stigma and discrimination, and more. The majority of these models address a significant and 
specific aspect of the HIV/AIDS program design, and the siloed approach driven by the 
models results in an inability to predict, or even hypothesize, the impact of the model 
concepts on controlling the HIV/AIDS epidemic. 
The Resource Allocation for Control of HIV (REACH) model is designed to determine 
the most effective allocation of available HIV funds and the optimal balance between 
treatment, prevention, and palliative interventions46. To accomplish this, the REACH model 
implements various inputs (e.g. setting description, epidemic data, intervention status, scale-
up and health care costs, resources, etc.) and uses a unique statistical model to calculate 
funding impact and determine optimal funding allocation (see Figure 6: REACH Model). The 
REACH model operates on five basic insights: 1) simply scaling up the current portfolio of 
investments may not be the best choice, 2) different objectives lead to different allocations, 
3) the length of the planning horizon is important, 4) choosing between allocations involves 
trade-offs between different objectives, and 5) the optimal allocation of resources is likely to 
change with the setting, even for relatively similar epidemics.  
 40 
 
Figure 6: REACH Model 
The study PI used the REACH model to create and develop the tailored conceptual 
model depicted in Figure 7: 90-90-90 Cross-cutting Factors Conceptual Model, and to 
categorize the mediating factors at each juncture in the 90-90-90 target cascade. The 90-90-
90 cross-cutting factors conceptual model assumes the factors that cut across the entire 90-
90-90 continuum (resources, setting description, and key populations) are the most impactful 
and significant in attaining target achievement. These factors are augmented and facilitated 
through the leadership involved at each juncture of 90-90-90 target cascade.  
 
Figure 7: 90-90-90 Cross-cutting Factors Conceptual Model 
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Study Approach and Methods 
A three-stage mixed methods approach employing the use of quantitative data 
analysis and qualitative data collection and analysis was required to answer the question: 
What practices and factors led to Botswana’s 90-90-90 achievement  
and how can the lessons learned be adapted and implemented  
in other sub-Saharan African Countries? 
And achieve the study aims: 
1. Describe the current state of 90-90-90 from a global, regional (sub-Saharan Africa), 
and country (Botswana) perspective and assess the robustness of data collected to 
track achievement of the 90-90-90 targets.  
2. Develop an in-depth case study identifying how Botswana achieved 90-90-90 and 
identify best practices responsible for this achievement. 
3. Develop an approach for recognizing, highlighting, and adapting lessons learned 
from Botswana to support stakeholders involved in the SSA HIV response to achieve 
the 90-90-90 targets and HIV epidemic control readiness. 
The introduction of this study (Chapter 1) addresses the current state of 90-90-90 in 
Botswana and SSA, and the robustness of 90-90-90 data collection is assessed through the 
examination of UNAIDS data collection methods and analysis (Chapter 4), meeting aim 1. 
The review of the literature (Chapter 2), together with key informant interviews (Chapter 5), 
UNAIDS data collection analysis, and discussion (Chapter 6) form the entirety of an in-depth 
case study identifying the best practices and factors responsible for Botswana’s 90-90-90 
achievement, meeting aim 2. Lastly, the application of lessons learned from Botswana’s HIV 
experience to the development of the HIV Epidemic Control Readiness Framework (HECRF) 
(Chapter 7) reinforce the high level factors (resources, setting description, and key 
populations) detailed in the conceptual model (Figure 7) that influence Botswana’s 90-90-90 
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achievement; the approach toward HIV epidemic control and the HIV Epidemic Control 
Readiness Framework (HECRF) (Chapter 7) produce a tailored model that can be adapted 
and localized to the context of the SSA country looking to improve its 90-90-90 achievement 
and HIV epidemic control readiness, meeting aim 3. 
During the first stage of research, quantitative global data from UNAIDS was analyzed 
and a systematic literature review (Chapter 2 of this paper) was conducted to inform how 90-
90-90 target and treatment cascade data are quantified, describe the current state of the 90-
90-90 goals, and derive insights from published literature relevant to the background, 
environment, and actions precluding Botswana’s 90-90-90 achievement.  
The second stage of research involved analysis of qualitative data, collected through key 
informant interviews to assess the social, political, economic, and policy drivers in Botswana. 
Moreover, the data collected through KIIs was designed to balance the quantitative analysis 
in stage one of the research with an anthropological perspective. The qualitative research 
aimed to augment the learning from the literature review and identify the potential catalysts 
and best practices responsible for Botswana’s early achievement of the UN’s 90-90-90 
goals. 
In the third stage of research, synthesis of the quantitative and qualitative information 
from stage one and two informed an approach toward HIV epidemic control, including the 
creation of the HIV Epidemic Control Readiness Framework (HECRF). The HECRF 
recognizes and highlights lessons learned from Botswana’s 90-90-90 goal achievement and 
provides a methodology and approach for SSA countries to adapt and acculturate these 
learnings to their own unique environments.  
Data Collection and Analysis 
90-90-90 Quantitative Data Analysis Procedures  
This study relied solely on UNAIDS as the treatment cascade and 90-90-90 target 
attainment data source, as the methodological rigor for calculation is considered the gold 
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standard, and because the use of one select data set ensures consistency and replicability 
of assessment. UNAIDS provides revised global, regional, and country-specific modeled 
estimates of the HIV epidemic on an annual basis. To discover how the lessons learned from 
Botswana’s 90-90-90 achievement can be adapted and applied in other countries, 
understanding exactly how 90-90-90 and HIV treatment cascade data are derived was 
critical. Analysis of UNAIDS data collection procedures and limitations therein supported the 
assessment of data validity and reliability by defining the methods for deriving the 90-90-90 
modeled estimates and identifying known data limitations.  
Key Informant Interview (KII) Qualitative Data Collection and Analysis  
Qualitative research in this study, in the form of KIIs, explores the social, political, 
economic, and policy influences that cannot be derived from analyzing UNAIDS data alone. 
Leveraging experienced stakeholder perspectives through qualitative research augments 
this study’s design by strengthening the reliability of conclusions and decreasing the threat to 
validity born of mono-methods bias.  
The PI used a maximum variation purposive sampling approach47 to identify experts 
whose experience and expertise could provide insight into the nuances and drivers of 
Botswana’s 90-90-90 achievement. Major stakeholder categories and groups used to identify 
KII participants are shown in Table 5: Targeted Key Informant Categories and Groups. 
The PI identified 30 potential stakeholders and 17 organizations across the five 
stakeholder categories depicted in Table 5, whose experience and expertise could provide 
insightful understanding of Botswana’s 90-90-90 achievement. Recruitment continued until a 
stakeholder refused to participate, or until four consecutive contacts went unanswered. 
Interviews included semi-structured, structured, and open-ended questions to gather data 
related to the practices, environmental, social, political, and policy trends that catalyzed 
Botswana’s achievement of the 90-90-90 targets. The interview script was modified based 
on the interviewee stakeholder category (see Table 5) and to account for answers given to 
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preceding questions. The purpose of these changes was to reduce forced repetition by the 
interviewee (in the instance they had provided the answer in a preceding question) and to 
target the questions to the specific experience of the interviewee to produce more robust 
insights related to Botswana’s 9-90-90 achievement. See Appendix Exhibit 1 (AE1) for the 
key informant interview script and guide. All interviews were conducted and transcribed via 
the Zoom meeting functionality. Interview transcripts were de-identified and coded by the PI 
and one additional researcher to identify thematic and categorical patterns. 
15 of the 30 (50%) stakeholders invited participated in the interviews. Of the 
stakeholders not included in the study, three explicitly refused to participate (citing advice 
from internal legal or communications counsel), six did not respond to any of the email and 
follow-up requests, and six responded but were either lost in follow-up (e.g. did not respond 
once requested to set an interview date) or were unable to schedule a meeting during the 
interview phase of the study. 







CHAPTER 4: UNAIDS DATA COLLECTION METHODS AND ANALYSIS 
UNAIDS is responsible for tracking the global HIV epidemic. The organization 
provides revised global, regional and country-specific modeled estimates annually, using 
epidemiological and programmatic data collected by country teams4. Each country team, 
comprised mainly of demographers, epidemiologists, monitoring and evaluation specialists, 
and technical partners, uses UNAIDS-supported software, called Spectrum, to develop 
annual HIV estimates4. In addition, UNAIDS relies on systematic literature reviews and 
analyses of raw study data by scientific experts to develop assumptions about the 
effectiveness of HIV program scale-up, transmission patterns, and disease progression4. 
Estimates related to the number of people on ART and women accessing PMTCT (which 
inform HIV prevalence rates) are reviewed and validated by partners, including UNICEF, 
WHO, PEPFAR, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and others4. 
UNAIDS reviews all final submitted files by country to ensure the results are comparable 
across regions and countries over time4. 
Epidemiological data for countries and regions where the epidemic is considered low 
level (e.g. Europe) are derived from key population surveillance or from HIV case reporting 
data4. Epidemiological data for countries and regions where there is a sustained epidemic 
within the general population (e.g. sub-Saharan Africa) consists of prevalence results from 
pregnant women attending antenatal clinics and from nationally representative population-
based surveys4. Population-based surveys are more robust in informing estimates of 
national HIV prevalence, as they include men and have broader geographical coverage than 
surveillance of antenatal clinic data, but they occur less frequently4. Moreover, some 
countries in SSA have not conducted population-based surveys in recent years4. 
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Calculating 90-90-90 Targets 
Country-level progress against the 90–90–90 targets is constructed using data from 
Spectrum, the Global AIDS Monitoring (GAM) tool, and (for specific countries in Europe), the 
Dublin Declaration monitoring process4. Estimates of the number of PLHIV are developed for 
countries with populations greater than 250,000 people. In 2018, 170 of 193 countries and 
territories reported estimates for the number of PLHIV, and of those, UNAIDS published the 
estimates for 1374.  
Estimates for the first 90 category (i.e. the number of PLHIV who know their status) 
are developed by UNAIDS based on the most recent HIV program and surveillance data, 
nationally representative population-based surveys, and the 2018 modeled estimates for 102 
countries4. For some SSA countries (n = 28), in 2018, a new mathematical model called the 
First 90 (F90) was used to estimate the number of PLHIV who knew their status4. The F90 
model uses population-based surveys together with HIV testing service program data and 
country-specific HIV epidemic data from Spectrum to produce first 90 estimates4. Estimates 
for the second 90 (i.e. the number of PLHIV accessing ART) and the third 90 (i.e. the 
number of PLHIV who are virally suppressed) are reported by countries through GAM and 
Spectrum. In 2018, 143 countries, representing 85% of all people on treatment, had publicly 
available estimates of the number of PLHIV on treatment. For the third 90, UNAIDS aims to 
ensure viral suppression reporting is reflective of the number of virally suppressed people 
and not the number of tests performed, by allowing only a person’s last test result from the 
reporting year to be submitted to Spectrum4. Existing challenges in using country-reported 
data to understand the number of PLHIV accessing treatment and to monitor the viral load 
suppression target are discussed in the limitations section. 
Limitations of HIV Data Collection 
Despite the rigor of UNAIDS data analysis, many countries still face challenges in 
determining their national care continuum48. Reflecting the complex HIV response, individual 
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site-level systems for clinical and program management, monitoring and evaluation systems, 
and inconsistent methodologies have proliferated in number, type, and complexity, resulting 
in non-standard data collection methodologies across different countries48. Data for a large 
number of interventions are gathered by a diverse set of stakeholders for a variety of 
purposes; this practice dilutes the desired impact of the commitment to standardize country-
level monitoring and evaluation systems. 
A non-standardized approach and lack of complete data for determining the national 
continua renders it difficult to ascertain whether countries are on track to achieve the 90-90-
90 targets, or if countries who UNAIDS declared to have achieved 90-90-90 have actually 
done so. Reported data are often presented without describing the estimation methods used 
to calculate the individual indicators, and care continua for key populations often rely on 
lower-quality estimation methods48. The lack of standardized and quality methods impacts 
global interpretation of the 90-90-90 target results48. To subjectively evaluate 90-90-90 
progress, a critical review is required of not only the reported results, but the methods used 
to derive the care continuum48.  
Population-based surveys produce nationally representative and internationally 
comparable estimates of demographic, health, and social indicators; they are more rigorous 
than HIV surveillance systems, including those based on program registers4. Despite the 
greater utility of population-based surveys in estimating the HIV epidemic, they tend to be 
expensive to administer. Countries in SSA that have not conducted population-based 
surveys in the last several years instead adjust HIV prevalence levels based on comparisons 
of antenatal clinic surveillance and population-based survey data from other countries in the 
region4. While this methodology provides an analogue for assessing HIV prevalence, 
UNAIDS recommends exercising caution in interpreting results in cases where the last 
population-based survey was conducted more than five years ago4. 
Additionally, while Botswana is an exception, many countries lack national identifiers 
that would facilitate a national cohort approach to HIV care and monitoring, and furthermore, 
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anonymous and unlinked test-and-treat services may compromise the national care continua 
for SSA48. Without patient identifiers to facilitate a cohort approach, developing an accurate 
care cascade by linking the first 90 (individuals who know their HIV status) to care (the 
second 90) and ultimately, to outcomes (the third 90) presents a significant challenge. 
To account for these country-level uncertainties, UNAIDS HIV estimates employ 
upper and lower bounds across the estimate range – the higher the bound, the greater the 
uncertainty of the data4. While the range of uncertainty aims to quantify estimate confidence, 
the range may not fully capture uncertainty in the reports4. 
Estimating Knowledge of Status (The First 90) – Limitations to Data Collection 
Dependency on modeled UNAIDS estimates or national estimates using antenatal 
clinic or other subpopulation data does not, in practice, demonstrate high levels of 
consistency with population-based HIV surveillance. For example, recently completed 
population-based surveys found incidence estimates in Zimbabwe that were approximately 
half of those reported by UNAIDS48. Moreover, data derived from HIV surveillance systems 
can introduce a number of biases; for example, a country’s measure of the first 90 may be 
underrepresented if not all people diagnosed are reported to the surveillance system in a 
timely manner4. Overestimates of knowledge of status may also be introduced if people are 
included on a register more than once (e.g. seen at two different clinic locations) and 
duplicate records are not detected. Similarly, if people who die or move to a different country 
are not removed from the system, the number of PLHIV will be overstated. 
Estimating Receiving ART (The Second 90) – Limitations to Data Collection 
The majority of countries do not describe what criteria are used to define “receiving 
or on ART,” and varied defined program measures and guidelines arise from different 
groups. For example, the International Association for Providers of AIDS Care (IAPAC) 
guidelines recommend using a defined program measure, such as at least one drug pickup 
during the measurement period, while the WHO guidance recommends that ART patients 
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seen within 90 days of a last drug appointment (excluding those who are deceased) are 
considered to be receiving ART48. 
The second 90 may be overestimated if people who transfer from one facility to 
another are reported by both facilities as receiving treatment. Similar to data collection 
limitations of the first 90, if people who have died, disengaged from care, or emigrated are 
not identified and removed from treatment registries, treatment numbers may be overstated4. 
In contrast, underestimation of treatment numbers may occur if not all clinics report the 
complete number of PLHIV on treatment or in a timely manner. 
Estimating Viral Suppression (The Third 90) – Data Limitations  
Viral load monitoring is required to reach the target of the third 90. Botswana was the 
first country in SSA to implement wide-scale viral load monitoring; in contrast, the majority of 
SSA countries rely on samples at the national laboratory to infer the number of people on 
ART who are suppressed48. Facilities not offering viral load testing, and the fact that facilities 
that do offer testing may not be representative of the care available at facilities without viral 
load testing4, may lead to either overestimation or underestimation of the viral load measure.  
In settings where viral load testing is not standard, viral suppression rates may be 
underestimated or overestimated. For example, when patients who are provided a viral load 
test simply to understand their drug resistance profile test positive for drug resistance, and 
these data are used to calculate viral suppression rates, overall viral suppression may be 
understated. If, on the other hand, people who are no longer in care do not have viral load 
measures, then the rate of viral suppression may be overstated48. An additional challenge in 
measuring the accuracy of viral load suppression estimates is that UNAIDS requests annual 
viral load testing results only for people who are on treatment and eligible for testing4. If viral 
suppression is achieved by people newly initiated on treatment, but they have not been 
offered a viral load test, they will incorrectly be counted as not suppressed, and skew the 
viral suppression rates to be understated. 
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While considerable variation exists in HIV data collection and reporting 
methodologies, the UNAIDS data set is considered the most authoritative and extensive data 
collection on HIV epidemiology, program coverage, and financing. With room to improve 
upon its limitations, the UNAIDS data set enables ambitious, quantitative, measurable, and 






CHAPTER 5: KEY INFORMANT INTERVIEWS 
The stakeholders included in the KII portion of the study represent the diverse 
organizational ecosystem committed to Botswana’s HIV response. All of the stakeholders 
who participated in the KIIs are considered experts in Botswana’s HIV response, 90-90-90 
target attainment, or both. Expert means the stakeholder has comprehensive and 
authoritative knowledge about either HIV in Botswana and the ensuing approach to control 
the epidemic, the 90-90-90 target framework, framework execution, or a combination. 
Table 5 details the KII stakeholder categories and groups. Stakeholder categories 
include: 1) in-country (Botswanan) government and ex-government officials working within 
the NAP, and HIV care practitioners; 2) public or non-governmental organization affiliates 
who work for not-for-profit NAP implementing partners and/or funders; 3) private affiliates 
who work for for-profit companies dedicated to controlling the HIV epidemic and who have 
specific experience in Botswana; 4) ex-country (outside Botswana) government affiliates 
who support the HIV/AIDS epidemic control work in Botswana, or who work for global bodies 
dedicated to HIV epidemic control (including funders), and/or implementing NAP partners 
both on the ground and outside of Botswana, and; 5) academic affiliates, both on the ground 
and outside of Botswana, partnering to control the HIV epidemic. Of the thirty expert 
stakeholders targeted, 15 participated in the interviews. 
Key Findings 
KII’s described four central themes contributing to Botswana’s 90-90-90 
achievement: 1) culture, encompassing political will and partnership; 2) resources; 3) 
attention to key populations, and; 4) data collection and reporting.  
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Culture is defined by the customary beliefs, social forms, norms and values, material 
traits and features of everyday existence that, in their aggregate, form a “way of life.” Culture 
was mentioned across all five KII stakeholder categories and, based on the significance key 
informants attributed to culture and its impact on Botswana’s HIV response, is the most 
important factor contributing to the country’s 90-90-90 achievement. According to an in-
country HIV healthcare practioner, the “[Botswana] culture is responsible for the system of 
social protection… and the [government] priority to take care of our most vulnerable 
populations”.  
Two sub-themes within culture garnered considerable attention from interviewees: 
Political Will, defined by the extent of committed government support among key decision 
makers to administer programs geared toward HIV 90-90-90 target attainment and epidemic 
control, and Partnership, defined as the individual people, collective groups, businesses, 
government, not-for-profits etc. that engage in activities and share knowledge, expenses, 
benefits, interests and investments in Botswana’s HIV response. “Botswana as a country 
has always been committed to providing… ART to its citizens. [The country’s ability to run] 
one of the oldest treatment programs [starting] when… the epidemic was really bad is a 
reflection of the commitment and political will from the government of Botswana” noted an 
ex-country government affiliate. Political will was the most cited theme across all stakeholder 
categories, while partnership was mentioned by every stakeholder category with the 
exception of ex-country government affiliates. Hallmarks of successful partnership were 
outlined by a for-profit NAP implementing partner key informant; “good partnerships [in 
Botswana] come from a shared vision, shared objectives, and being totally open and 
transparent about different policies, and, intent. So there's no hidden agendas”. 
The cultural backdrop of Botswana is different from many SSA countries. Democratic 
principles underpin the open political system, which some KIIs argue is a factor leading to 
the country being labelled the “African Exception.” Botswana has developed a system of 
social protection where the government will provide for its citizens when they cannot provide 
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for themselves. “The government [of Botswana is] committed to reaching… every patient 
with lab work, viral load testing, ART therapy, and support… you have labs in every district 
and viral load testing in virtually every facility” said a not-for-profit affiliate. This system is 
born of the engrained cultural beliefs that have developed in Botswana over time.  
KII’s drew on Botswana’s history to illustrate the cultural components responsible for 
its HIV response. Botswana gained its independence from Britain in 1966, and the way the 
constitution governing Botswana was constructed contributes to the spirit of partnership and 
political will that have underpinned Botswana’s HIV response. In Botswana, both during and 
after British rule, chiefs are responsible for governing and presiding at kgotla (the place in 
the village serving as a traditional gathering spot, court, or administrative body, as required 
by the situation). Chiefs seldom provide their opinion in the kgotla until all people have had a 
chance to speak; to illustrate the people-centered cultural approach in Botswana, an in-
country HIV healthcare practitioner shared that "chiefs don’t eat first… the chief eats last 
because he has to make sure everyone has eaten”. According to the same practitioner, 
“Kgosi ke Kgosi ka batho” is a Botswanan saying that conveys the importance and role of 
the chief; it means “a chief is a chief through the will of the people.” As part of tradition, 
chiefs consult with the people before making important decisions, and the custom of 
consulting and seeking consensus is deeply rooted in and respected in Botswana.  
Consultation and partnership, according to an in-country HIV healthcare practitioner, 
was “inculcated into our constitution when it was [formed]… in 1965 so … [that] the chief 
cannot make a decision, for example, about moving or fighting another tribe… without 
consulting the [people]… consultation and partnership become the keys… Our system has 
been built such that… consultation makes sure that every single citizen is taken care of.” As 
Botswana looked toward independence, the Botswana Democratic Party (BDP) led the 
charge to form the constitution. The strong Botswanan tradition of equal distribution and 
consultation was embraced by the BDP and influenced the way they developed and 
implemented policy. Candid communication and voicing of individual opinion, both traditions 
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commonly seen at the kgotla, were transferred to the democratic election system and are 
detectable in the Botswanan Bill of Rights built by the BDP, which protects freedom of 
speech and supports wide-spread consultation and partnership. Incidentally, the BDP has 
won every presidential election since Botswana gained its independence from Britain.  
At roughly the same time that Botswana achieved its independence, the first diamond 
mine was discovered. Seeking to ensure its mineral wealth resulted in prosperity for the 
nation and its citizens, the BDP contributed significant effort to avoiding the severe 
economic, political, and social challenges of managing mineral wealth that surrounding 
countries had endured. “Other [SSA] country constitutions were retained under very different 
circumstances. For example, in 1980 [another country in SSA] already knew… [it] had fertile 
farms [and] diamonds… the way [their] constitution was written had a lot of loopholes 
[making it easy for] the politicians to…rip off whatever they [could]… [the rest of] Africa was 
kind of the same. [Country constitutions were] written by the United Nations, [and had] 
loopholes where people can get rich while others stay poor,” noted an in-country government 
affiliated stakeholder. Similarly, an implementing NAP program partner outside of Botswana 
stated, “in other countries… the mining infrastructure… has in no way benefited the people 
of the country. If anything… it has brought them heartache, pain, and lots of militias. So… 
the contrast between… mineral rich countries is striking because in [Botswana] you had the 
political will to set up something that was beneficial to the country… [and] have money to 
then spend on the right things. In other cases, the countr[ies] continually hemorrhage funds.” 
According to several in-country stakeholders, Debswana, Botswana’s diamond 
mining partnership with De Beers, is the largest global supplier of De Beers diamonds, and it 
transfers more than half of its profits to the Botswana government. “When all these 
resources were discovered in 1967 - mainly the diamonds - then all of the resources were 
[invested back into the people] because the constitution required being equal and 
distributive” said an academic affiliate on the ground in Botswana. The profit from diamonds, 
in keeping with the principles of equal distribution and leaders serving the people, are 
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heavily reinvested by the government into health care, education, water supply projects, and 
grants to reduce poverty. “Debswana has created an extremely strong HIV program in all of 
the mines that they run… adhere to all guidance and the people [whom the Debswana 
programs impact] are extremely well taken care of,” said an ex-country government affiliated 
NAP implementing partner. 
Political will and partnership are key variables within Botswana’s engrained culture 
backdrop regarded as positively impacting Botswana’s 90-90-90 target attainment. In the 
case of Botswana, political will, or the commitment of government to combat the HIV 
epidemic, is inextricably linked to the concept of partnership in this context. The consultative 
and consensus-building framework from which Botswana grew is evident in the way the 
government approaches enactment of HIV policy. The approach to policy extends beyond 
government debate and is managed through partnership and consultation with various 
expert stakeholders. A foremost global expert on HIV who is also an in-country healthcare 
practitioner said “[the government] is quite inclusive and consultative, which is the cultural 
side of [Botswana]… I am not employed by Botswana; I'm not a government employee, [but I 
partner with the government]. I will tell you, no HIV drug will be bought without me knowing 
or approving it, even though I sit outside government. That is how inclusive our government 
has been - they acknowledge that within government, you may not have everyone who 
knows everything. [My key population expertise] allows me to make the best decision [about 
key population treatment regimens] and [since] I am not involved in [ART] procurement, I 
[don’t stand to] benefit [from my] recommendation in any way. I am not worried about 
promotion within the MOH, so I'll always tell [the government] the truth. I think that is… 
something that is lacking in other countries - where either you are within government or 
outside, there [is no] integrat[ion] between the two. [When this happens, the government 
doesn’t] get the right information; because if you are within the system, you may have other 
motives as to why you approved [specific NAP protocols].” Partnering with stakeholders 
outside of the government provides an alternative lens to assess policy and legal proposals 
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and serves as a checks and balance system to ensure government/MOH employees do not 
make decisions based solely on personal promotion criteria. Due to the deeply held belief 
that chiefs, leaders, and government are there to serve the people, political will comes 
naturally in Botswana. 
Political will and partnership have been noteworthy aspects of Botswana’s HIV 
response since the beginning of the epidemic. According to an in-country academic affiliate, 
“the political commitment from government to find the best possible partners, [and dedicate] 
resources to making sure people survive, and always using the best form of evidence and 
the best types of drugs that were available and affordable to provide the best care for the 
citizens of this country” has been a hallmark of the Botswanan HIV response. The same key 
informant continued to explain that while it took time formulate the Botswanan HIV response, 
partnership catalyzed the rapid innovation and improvement to the NAP that followed; “the 
first [HIV] case in Botswana was in 1985 and between 1985 and… 1996, there wasn't much 
happening in the country [for HIV because]… first we needed to figure out what [the problem 
was]… [At the time] we just knew there was high mortality with something that was 
happening. Secondly, there was not treatment in the country during those times. So the only 
way was prevention. So the government, alongside partners, spent quite a lot of resources 
trying to come up with a plan… [for] prevention. So the first phase of the response to HIV 
was mainly based on prevention… The next phase [assessed alongside partners was aimed 
at]… prevent[ing] mother to child transmission, [and ushered in] the first anti-HIV drugs in the 
country… Then, from 2002 on is when we had [a] full national program. And it came about 
because, if you remember around that time, none of the African presidents would 
acknowledge that HIV was [a problem in their country]. [But] it was a problem. [To those 
African president’s, HIV] was more of a conspiracy theory than a disease. So our president 
was the first in 2001 to acknowledge [the HIV epidemic] internationally at the United Nations 
and talk about the [possibility of the] nation becoming extinct. So then we started to have a 
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lot international partner organizations and pharmaceuticals coming in helping set up the 
original HIV program.”  
President Mogae’s acknowledgement of the dire consequences of HIV in Botswana 
ushered in an era of political will and partnership, resulting in programs committed to HIV 
education, prevention, and evidence-based research to inform the best possible patient care. 
According to an in-country academic affiliate, since then, Botswana “has gone on from 
strength to strength, essentially becoming one of the first national programs… on the 
continent… to provide HIV testing, treatment… viral load monitoring… and resistance testing 
early and free of charge”. 
In-country stakeholder KII description of the historical landscape in Botswana signals 
culture, and specifically political will and partnership, significantly underpin Botswana’s 90-
90-90 success. Remarkably, KIIs without knowledge of Botswana’s history consistently cited 
partnership and political will as pivotal factors within the Botswanan culture that advanced 
90-90-90.  
Resource is defined as the stock or supply of money, materials, staff, and other 
assets that are required for Botswana’s HIV response to function sustainably. Of note, in the 
context of Botswana’s HIV response, “resource” should be considered in financial terms; this 
is because all resources (e.g. materials, staff, etc.) can be quantified by the monetary 
expense required to procure them. Botswana’s ability to dedicate and control the resources 
used to combat its HIV epidemic was acknowledged across every stakeholder category as a 
significant factor in driving toward 90-90-90 target attainment. Specifically, Botswana’s World 
Bank income designation as a UMIC featured prominently during the KIIs. An implementing 
NAP partner outside Botswana noted “Botswana is in this unique position in Sub-Saharan 
Africa where they're an upper middle-income country that can… afford their own ART… 
[which] gives [the government] more bargaining power to be able to set their own agenda”. 
Similarly, a for-profit NAP implementing partner noted Botswana’s UMIC status as enabling 
the “financial independence to make decisions about where they buy their ART from… [the] 
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money from [Botswana’s] diamond mines effectively means that they can choose how and 
where they invest in HIV care, which is completely different from [most other SSA 
countries].” 
KIIs across all categories acknowledged that Botswana is rigorous in its assessment 
of resource spend. For example, in 2016 “a consultative and consensus building process 
with all key partners”49 produced the Botswana Investment Case which analyzed trends and 
gaps in HIV planning, program implementation, and funding to determine the cost 
effectiveness of several different HIV program strategies49. A not-for-profit NAP 
implementing partner noted the “the Botswana Investment Case… [demonstrated] how… to 
reduce new infections with a strategy and how… to keep more people virally suppressed, 
[and how upfront investment over the long term] would be cost effective.” Similarly, a for-
profit NAP implementing partner noted the 2016 Botswana Investment Case provided the 
“business rationale for funding rapid treatment by demonstrating that test and treat as a 
strategy leads to the greatest overall reduction in the number of new [HIV] infections.” 
Ultimately, the Botswana government was the first SSA government to choose a “Treat All” 
approach based on overall, long-term cost savings, despite “Treat All” being the most 
expensive strategic option in the near term as detailed in the Botswana Investment Case. 
The Botswana government was able to implement the “Treat All” approach using its 
preferred ART (despite international donors having an alternative preferred ART) because 
resource and funding came from the domestic budget. 
According to an academic affiliate on the ground in Botswana, the “selectivity of the 
Botswana government about what they will allow funding for” is enabled by domestic funding 
facilitating the majority of HIV resource dedication. In addition to “Treat All”, the government 
of Botswana uses “funding provided to support the training of HIV caregivers and, instead of 
bringing in caregivers that leave, they upskill [Botswanan] caregivers and procure equipment 
which stays in country… [the government also uses financial resources to] train fresh out of 
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medical school doctors on HIV care [through a course called] AIDS Care Clinical 
Fundamentals [which was] adapted from the WHO to fit the Botswana environment.” 
Botswana’s ascension to a UMIC WB income classification was compelled by the 
same factors, like its management of mineral richness, that allow domestic share of HIV 
resource allocation to outweigh donor share. Botswana’s ability to harness and reinvest 
resources into its people and programs and the weighted allocation of domestic versus 
donor resource spend are responsible for the governments autonomy in directing its NAP. 
The retention of government NAP command and control is inextricably linked to the 
command and control of its resources. This allows Botswana to create fit-for-purpose NAP 
protocols and helps protect and sustain the country’s 90-90-90 achievement, even in the 
event donor funding is removed. 
Key populations, as defined in the KIIs, are the populations at highest-risk for 
transmitting and acquiring HIV. KII’s expanded the definition of key populations to extend 
beyond the definition by WHO – MSM, transgender people, people who inject drugs and sex 
workers – and include non-citizens, migrants, and refugees. Key populations were 
mentioned across most of the stakeholder categories during the KIIs. 
Stakeholders who proactively referenced key populations during the KIIs 
acknowledged the progress Botswana has made in reaching these populations while 
simultaneously noting room for improvement. A not-for-profit implementing partner on the 
ground in Botswana noted “we have done well so far, but there are still priority populations, 
key populations, that if we don't tailor make our interventions for, we will never ever reach 
epidemic control… [In] female sex workers, men who have sex with men, non-nationals… 
[and] adolescent girls and young women… [we] still see high rates of new infections… [and] 
they don't have a health seeking behavior… If we can be a little bit more targeted, a little 
more specific and a little bit more rigorous in reaching these groups, then we'll be able to 
reach 95-95-95.”  
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The view of many stakeholders who mentioned key populations as a critical 
component in achieving the 90-90-90 targets was that ongoing transmission will prevent 
epidemic control, and key populations are more likely to transmit HIV than the general 
population, rendering specific and sustained attention focused on these groups a necessity. 
“We will not be able to achieve epidemic control if we leave key populations behind because 
the contribution of that small population to the epidemic is immense” said a not-for-profit 
NAP implementing partner. Similarly, an ex-country academic affiliate stated, “we need to 
get to 90-90-90 in every population, especially key populations, and hard to reach 
populations across regions. We can't do selective cherry picking [for who has access to 
ART] … You need to make sure [testing, linkage to care, treatment, and retention in care] is 
applicable to everyone. [Not reaching key populations is] one of the dangers to 90-90-90 and 
achieving epidemic control”. 
Most KIIs who mentioned key populations suggested that non-citizens who have HIV 
and cannot access ART under the current “Treat All” policy could ultimately set back the 90-
90-90 gains achieved in Botswana. “We really need to change things… to sustain our gains 
and… to make sure that we don't backslide and lose all the effort we've put in. One of the 
biggest [issues] in [Botswana] is the provision of ART [for] non-nationals. [This] is a big issue 
because we have provided ART to [citizens] for so long… and we pride ourselves in being 
able to provide that service for citizens and actually pay for it. When it comes to providing 
[for] non-nationals, it becomes an issue of cost… that will be the biggest loop to close… to 
really sustain our gains in the [HIV] response,” said a not-for-profit implementing NAP 
partner. To explain how Botswana found itself in a position of not offering ART to migrants, 
an academic affiliate outside of Botswana said, “Botswana was one of the first countries to 
offer free ART to its citizens. And I think at the time there was a concern that everybody from 
every other country would… flood its borders and come for ART. So [the government] made 
it policy that [free ART] was only for citizens.” According to in-country not-for-profit 
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implementing partners and ex-country academic affiliates, treatment for non-citizens is 
available to refugees living with HIV who remain within the confines of refugee camps.  
According to not-for-profit and academic key informants who work with key 
populations, specific programs in Botswana have been dedicated to finding and treating sex 
workers and MSM. However, transgender and injectable drug users have far less resources 
devoted to their treatment and care, and the laws making it illegal to be part of the 
aforementioned groups may drive continued stigmatization and the inability for these groups 
to seek help. “[We can] shift [stigma and treatment of key populations by] training healthcare 
workers on stigma and discrimination and providing key population friendly services in the 
health setting… healthcare workers need to know about the barriers that keep key 
population communities from accessing services… [The government] doesn’t focus so much 
on [key population barriers] as [it does the] main HIV program, but there's work being done 
in sensitizing communities. There's work being done on the legal framework and trying to 
address the laws that make it difficult… for key populations to come out”. 
Botswana uses what they call “social networking” to reach key populations. The 
model invokes the peer educator methodology – when individuals are part of a broader key 
population group access care, they are provided with vouchers they can give to others in 
their key population network to receive care. A not-for-profit NAP implementer focusing on 
key populations explained the model; “peer educators who identify as either a female sex 
worker or MSM…(currently [we] focus only on those two key populations because we 
weren't able to find… huge numbers of the other key population groups like transgender 
individuals and people who inject drugs)... go out in the communities during outreach or 
during their own personal time and… identify other key population members who they then 
tell about the services we provide. So the key populations [are]… crucial in bringing in peers 
to access services”. This program has demonstrated high yield, particularly with sex 
workers, and the “snowballing” technique has demonstrated that PLHIV can be reached in 
non-traditional ways. 
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According to the KII’s, all key population programs in Botswana are donor funded 
(which may speak to the lack of priority the MOH has given these underserved segments). A 
shift in mindset and resources may be required to develop targeted programming for key 
populations. Training on stigma, discrimination, and the barriers keeping these populations 
from accessing care were cited in the KIIs as important shifts that need to occur. 
Additionally, analysis of the legal frameworks and laws that make it difficult for key 
populations to come out publicly was cited as a critical component in achieving epidemic 
control. 
Data is defined as the facts and statistics collected together for HIV reference and 
analysis. This theme was acknowledged by individuals in four of the five stakeholder 
categories; private affiliates (e.g. for-profit NAP partners) did not acknowledge data as a 
theme in Botswana’s 90-90-90 achievement. KIIs consistently questioned the strength of the 
data precluding Botswana’s 90-90-90 achievement; however, the resulting impression of 
whether the data overstated or understated 90-90-90 target achievement differed across the 
stakeholder category groups.  
The majority of in-country stakeholders believed the data underrepresented 
Botswana’s 90-90-90 target achievement, while stakeholders in other categories believed 
that data collected overstated 90-90-90 target achievement. An in country academic affiliate 
who assists the government with ART procurement said underrepresentation of 90-90-90 
target attainment is a function of “modelling issues” that are discredited based on what is 
“seen on a day to day basis [which] does not lend itself to the fact that there are too many 
people out there who don’t know their status.” The key informant continued to explain that 
“forecast[ing] for ART [requires using the modelled]… estimates to determine the quantity of 
ART… required for the program. And at the end of the day [there is] significant ART 
expir[ation]… The forecast say[s] that you have this number of people, so where are they?... 
It gets me… thinking [we are] probably over estimating [the number of PLHIV], which will 
accounts for some of the [ART] expiries... When I look at what's happened with the 
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forecasts, [and assess] the trends of people who are put on treatment and how the slope 
goes up and comes down [which is correlated to] changing the guidelines… [and triangulate 
these data points with] community testing data… I must ask myself the question are the 
numbers [reflected by modelled estimates] actual patients.” Another in country academic 
affiliate said “I think we have achieved 90-90-90; [but] we cannot prove it because our data is 
not the most curated of all data that you can find. We are currently working with UNIADS to 
verify that we have at least the 90-90-90 we think we have. It's just we cannot prove it.” 
Conversely, an ex-country government affiliate and NAP program implementer stated “there 
are serious concerns about Botswana’s actual numbers and we are very much looking 
forward to the Botswana AIDS impact survey … which will give us a firmer idea of where 
they are in terms of 90-90-90” while another ex-country government affiliate said “They've 
done a great job, but I wouldn't necessarily say they have achieved 90-90-90…[to do this 
requires] determining who is still undiagnosed and that's the hardest thing to do. You have to 
know if… the way we estimate pockets of undiagnosed HIV are accurate. Are the methods 
we use to determine the [testing and treatment cascade] accurate or not. Or maybe… there 
is no one else to reach and it's saturated because the population [of Botswana] is only 2 
million [people].”  
Spectrum, the UNAIDS data collection software, was cited by both groups as 
imperfect and not always fit-for-purpose to accurately assess 90-90-90 attainment. “We are 
looking at the inputs into Spectrum because Spectrum generate[s] the [90-90-90] numbers. I 
think the software design or the design of Spectrum… [has the] denominator wrong,” said an 
academic affiliate in Botswana. Above-country stakeholders (e.g. funders, implementing 
partners, and some academic institution affiliates) questioned the quality and kind of data 
used to denote Botswana’s 90-90-90 achievement, with one above-country key informant 
carefully stating, “it's not that the numbers are wrong, it's that they don't tell the whole story”. 
In-country stakeholders acknowledged the lack of robust data and spoke to anecdotal 
evidence (such as the amount of expired ART and the inability to properly quantify the first 
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90 without testing every human in Botswana) as corroborating the view that Botswana’s 90-
90-90 achievement has been underrepresented through the data. Whether stakeholders 
believed the data underrepresented or overrepresented Botswana’s 90-90-90 target 
attainment, the data methodology to estimate the pockets of undiagnosed PLHIV and the 
inability to ascertain the saturation point of finding these populations was consistently 
questioned.  
Additionally, there was agreement across stakeholder groups that population-based 
surveys produce a more robust and compelling data set than the modeled figures generated 
through Spectrum. All stakeholders were eagerly awaiting the publication of Botswana’s 
latest Botswana AIDS Impact Survey (BAIS), and cited problems with extrapolating and 
modelling data based on their most recent nationally representative HIV study. 
Key Informant Interview Summary and Analysis 
Key informants represent a diverse set of stakeholders with expertise and views 
related to Botswana’s HIV response, 90-90-90 achievement, or a combination of the two. 
Political will and partnership were viewed across all stakeholder groups as the cultural pillars 
primarily responsible for the country’s 90-90-90 achievement. Consultative partnering and 
the government’s commitment to combat HIV (i.e. the political will) have been noteworthy 
aspects of Botswana’s HIV response from the onset of the epidemic. Both partnership and 
political will are enshrined in the cultural and historical DNA of Botswana and stem from a 
deeply held belief that chiefs, leaders, and government are there to serve the people.  
Another significant factor contributing to Botswana’s 90-90-90 achievement is the 
government’s ability to harness and redeploy the stock or supply of money, materials, staff, 
and other resources in ways that positively impact the quality of life for the Botswanan 
people. Botswana demonstrates a mindful approach toward evaluating strategic options on 
the basis of cost effectiveness and where resource is best placed for optimizing NAP 
effectiveness. The 2016 Botswana Investment Case was commended by several 
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stakeholders and regarded as a best practice for its rigor of strategic analysis. Botswana’s 
UMIC WB income classification places the country in a unique position amongst SSA and 
signals greater potential to mobilize resources than its low-income country (LIC) and low 
middle income country (LMIC) neighbors. Botswana’s capacity to retain autonomy in 
directing its NAP is directly related to its ability to retain NAP purse strings. Botswana 
allocates enough domestic spend to its NAP to outweigh donor contributions. This effective 
resource allocation secures programmatic sustainability by refraining from donor 
dependence and allows the government to retain NAP command and control, thereby 
ensuring program practices are tailored to the particular needs of Botswana’s HIV epidemic. 
KIIs expanded the WHO definition of key populations to include non-citizens, 
migrants, and refugees. Interviewee’s regarded key populations as critical to achieving 90-
90-90 and HIV epidemic control since key populations are more likely to transmit HIV. 
Specific and sustained attention on key populations must go beyond general programmatic 
NAP capabilities to reduce HIV transmission in these vulnerable populations. Targeted 
programs for key populations should consider how to best engage PLHIV who participate in 
high-risk behaviors (such as injecting drugs) and those who are marginalized by society and 
fearful of accessing HIV services in the testing and treatment cascade. 
KIIs cited concerns about the strength of the data precluding Botswana’s 90-90-90 
achievement which echoed 90-90-90 data collection procedure limitations outlined in 
Chapter 4 of this paper. The constraint of using modeled data to inform 90-90-90 cascade 
estimates resulted in different and opposing perspectives as to whether the data overstated 
or understated 90-90-90 target achievement. Stakeholders across all categories agreed that 
population-based surveys are required to validate modeled data estimates and ensure 





CHAPTER 6: DISCUSSION 
In order to make the central question of what practices and factors led to Botswana’s 
90-90-90 achievement actionable and meaningful, this study examines what lessons learned 
can be adapted and implemented in other SSA countries. Botswana’s 90-90-90 target 
achievement demonstrates that HIV epidemic control is possible in resource limited settings 
with high HIV prevalence. However, Botswana’s unique position within the context of SSA 
means that simply adopting and transferring the practices that led to 90-90-90 achievement 
in Botswana may not produce the same results in other SSA countries. Therefore, to 
replicate the 90-90-90 achievement outcomes in other countries, the lessons from 
Botswana’s HIV experience should be acculturated and localized (i.e. adapted) to reflect the 
context, people, and environment they are intended to affect.  
The literature review, UNAIDS data collection analysis, and key informant interviews 
were designed to provide insight into what practices and factors led to Botswana’s 90-90-90 
achievement. The factors and lessons uncovered in the aforementioned sections of this 
paper reinforce the mediating factors (resources, setting description, and key populations) at 
each juncture in the 90-90-90 target cascade and validate the conceptual model designed 
specifically for this study (see Figure 7). The objectives of the literature review were to 
establish and assess the existing published academic knowledge relevant to the 90-90-90 
targets and Botswana; provide insight into what can be learned from Botswana’s HIV 
experience; and to identify themes that inform the best practices responsible for Botswana 
achieving the 90-90-90 targets. The aims of the UNAIDS data collection analysis were to 
define the methods for HIV treatment cascade data collection and the procedures for 
deriving 90-90-90 modelled estimates; to understand the data limitations and impact to the 
validity and reliability of reported 90-90-90 results; and to provide insight into how to improve 
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tracking, monitoring, and reporting of progress toward 90-90-90. The goal of the key 
informant interviews (KIIs), in turn, was to develop a more in-depth understanding of the 
social, political, economic, and policy influences that cannot be derived from analyzing 
secondary data alone. This chapter discusses and synthesizes the findings of the literature 
review, UNAIDS data analysis, and KIIs; Figure 8: 90-90-90 Achievement Lessons Study 
Synthesis depicts the factors, practices, and lessons responsible for Botswana's 90-90-90 
achievement, the overlap of lesson learned between the literature review, UNAIDS data 
collection methodology and analysis, and KII evidence base, and the relationship of these 
lessons to the key concepts and mediating factors that form the basis of this study’s 
conceptual model. 
  
Figure 8: 90-90-90 Achievement Lessons Study Synthesis 
This study demonstrates that resource and culture are the most important factors 
driving Botswana’s 90-90-90 achievement. Culture is the only factor discovered in this study 
contributing to Botswana’s 90-90-90 achievement that is not reliant on resources; instead 
resource mobilization and allocation is largely a function of the culture in Botswana. Since 
resource influences every other factor compelling Botswana’s 90-90-90 achievement, and 
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since Botswana’s culture influences resource allocation, it follows that Botswana’s culture is 
the most impactful factor compelling the country’s 90-90-90 achievement. Additionally, data 
collection methodologies should not be overlooked in their significance to 90-90-90 
attainment. Drawing on the axiom “what gets measured gets done”, means understanding, 
evaluating, and improving data collection methodologies will help country NAPs reach the 
right people in the right place and at the right time. Having high-quality data on the HIV/AIDS 
response enables ambitious, measurable, and time-bound targets, like 90-90-90, to be set 
for tracking progress and ensuring accountability. 
With the exception of culture, all other factors and lessons learned from the 
Botswana HIV experience are reliant on, or influenced by, the allocation of stock or supply of 
money, materials, staff, and other assets making resource a crucial component of 
Botswana’s 90-90-90 achievement (see Figure 8). For example, expanded ART coverage, 
partnerships and funding, and prevention programs/ behavior change are factors determined 
by both the literature review and KIIs as responsible for Botswana’s 90-90-90 success and 
have an enduring association to resource utilization. The adaptability of each of these 
lessons in other SSA countries requires allocating financial and/or human resources to 
facilitate their implementation. 
Domestic funding provides the majority of financial resources dedicated to 
Botswana’s NAP18 and provides the MOH leverage to push back against international 
donors who have an interest in implementing programs or treatment regimens differing from 
the MOH vision. For example, because the share of domestic resource spend on HIV 
outweighs the share of donor spend, Botswana was able to justify the implementation and 
use of dolutegravir, a drug that has changed the face of HIV with its potency and tolerability, 
ahead of a genericized or less expensive version becoming available, for treatment of 
PLHIV. The MOH was able to resist pressure from international donors to continue the use 
efavirenz, an efficacious yet toxic antiretroviral agent, and secure donor funding for 
dolutegravir nevertheless. Significant local funding allows Botswana to be selective about 
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any aid the country receives and how the aid is allocated. Controlling and retaining the purse 
strings for its NAP budget provides the Botswana government the autonomy and agility to 
develop fit-for-purpose country HIV programs and is a significant factor affecting Botswana’s 
ability to operate a sustainable and effective NAP. 
Botswana’s “Treat All” approach and first-mover status in adopting and adapting 
interventions designed to test, treat, and virally suppress PLHIV is largely related to the 
country’s ability to fund its own ART program. Development of health care infrastructure 
(including monitoring and evaluation, electronic patient tacking, and training of healthcare 
workers), alongside care innovation, (including decentralization of HIV care, nurse led 
prescribing, routine opt out for HIV tests and counseling, male circumcision, bringing the 
guidelines up to date, and viral load and resistance testing), are factors leading to 
Botswana’s 90-90-90 achievement derived from the literature review, and include and 
inextricable link to financial and human resource. 
SSA as a whole is largely constrained, in both human and financial resources, in its 
HIV response. As an UMIC50, Botswana has greater ability to harness and devote domestic 
resources to its HIV epidemic than its LMIC or LIC SSA country counterparts. However, by 
customizing interventions using local solutions, SSA countries may be able to adapt and 
implement lessons from Botswana within the context of their resource constraint. This 
concept is explored in depth in the Adapting Lessons Learned from Botswana’s 90-90-90 
Achievement section of this chapter. 
KII’s across all stakeholder categories echoed the significance of resource devoted to 
Botswana’s HIV response and implied a symbiotic relationship between the economic and 
social stability enjoyed by Botswana, and the resources devoted to its NAP. Without 
economic and social stability, it is unlikely that HIV and AIDS could be prioritized by the 
Botswana government, MOH, HIV community and allies; conversely, given the high rate of 
prevalence, prioritization of the HIV/AIDS epidemic and mitigating its detrimental 
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consequences leads to economic and social stability. This study demonstrates Botswana’s 
economic and social stability is largely a function of its culture. 
The customary beliefs, social forms, norms and values, material traits and features of 
everyday existence that, in their aggregate, form a “way of life” define the culture in 
Botswana. The commitment of Botswana’s government to confront and combat the country’s 
HIV epidemic, referred to as political will, and its dedication to partnership in its HIV epidemic 
control efforts, form an important part of the cultural backdrop that defines Botswana’s HIV 
approach and 90-90-90 target achievement. 
Defining cultural characteristics in Botswana that can be adopted and transferred to 
other SSA countries is a nebulous undertaking and in practice, is as unfeasible as it is 
undesirable. In the same way that the Americanization or Europeanization of African HIV 
programs do not yield the same health outcomes for Africa as they do in America or Europe, 
the Botswanization of African HIV programs is not an appropriate approach to tackling the 
HIV epidemic in SSA. To do so would result in the diminishment of African heterogeneity. 
Instead, acculturating the lessons learned from Botswana’s HIV experience to the SSA 
countries they are intended to affect will be more impactful than trying to acculturate other 
SSA countries to Botswana.  
For illustration, Botswana’s diamond mining partnership with De Beers largely 
accounts for how it funds its NAP. The Botswana governments investment of profits earned 
from natural resources into its communities and constituents is a function of the culture of 
Botswana. In contrast, several SSA countries outpace Botswana in mineral richness and 
natural resources; however, the resulting profits often fall into the pockets of government 
leaders instead of being reinvested back into the country. It is highly unlikely that mineral rich 
countries who do not currently invest profits from their natural resources back into their 
communities would find the Botswana paradigm a replicable or transferable solution. This 
demonstrates the complexity and inherent flaw in assuming reproducibility of Botswana’s 
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cultural principles of equal distribution and leaders serving the people in other SSA 
countries.  
Partnership and political will were stand-out cultural elements of Botswana’s HIV 
response. While neither political will nor partnership could be reproduced and transferred 
precisely as they occur in Botswana, in their high-level forms, both may be adapted to suit 
the cultural reality in other SSA countries. Partnership was identified as a significant factor in 
Botswana’s 90-90-90 achievement in three out of 10 articles in the literature review and 
political will and partnership were mentioned by the vast majority of stakeholders in the KII’s. 
In the case of Botswana, political will and partnership are intimately intertwined and have 
been since Botswana’s independence from England. While the confluence of political will 
and partnership in Botswana may serve as a benchmark for HIV advocates, patient groups, 
and supporters to strive for, creating this enmeshment in SSA countries where it does not 
currently exist will take time and dedication. Instead, focusing on small areas where political 
will and partnership can be seeded, and eventually thrive, may help build a foundation for 
future synergy between the two factors.  
Botswana’s achievement of the 90-90-90 viral suppression target (i.e. reaching 73% 
viral suppression of all PLHIV) was acknowledged by UNAIDS in 20179 with full target 
achievement (i.e. 90% of all PLHIV knowing status, 90% of diagnosed PLHIV receiving 
sustained ART, 90% of all people receiving ART achieving viral suppression) confirmed by 
UNAIDS in 20194. Gaolathe’s 2016 population-based study, 90-90-90 Antiretroviral Therapy 
and Virological Suppression Goals: A Population-Based Survey, conducted between 2013 
and 2015 found that 70.2% of people living with HIV had virological suppression. Since no 
population-based study has been published since, this study assumes modeled estimates, 
as discussed in the UNAIDS data collection and analysis chapter of this paper informed 
UNAIDS 2017 acknowledgement of Botswana’s 73% viral suppression attainment for all 
PLHIV. Furthermore, it is assumed modeled estimates inform UNAIDS 2019 confirmation 
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that Botswana achieved 91%, 92%, and >95% with respect to the three 90’s, for the same 
reasons. 
The limitations of modeled estimates defined in Chapter 4 result in a certain level of 
skepticism in the interpretation of 90-90-90 target results. The skepticism of the data and 
data reporting methodologies underpinning Botswana’s 90-90-90 achievement were evident 
in the key informant interviews, where interpretations of overstated or understated 90-90-90 
reach were split along ex-country/in-country stakeholder categories, respectively.  
This analysis confirms the findings of Granich et. al that deficiencies in standardized 
data collection methodologies impact the reliability of 90-90-90 results and impede 
comparisons across countries48. Granich and colleagues concluded that a rigorous review of 
not only the reported results, but also the methods used to determine the care continuum is 
required to subjectively evaluate 90-90-90 progress48.  
Adapting Lessons Learned from Botswana’s 90-90-90 Achievement 
The adaptability of the lessons learned from Botswana’s 90-90-90 achievement must 
be considered amongst the context, people, and environment in which lesson 
implementation is targeted. Botswana’s unique position as a UMIC means resources are 
more abundant than they are in many neighboring SSA countries. Since resource is the 
lynchpin in all factors (with the exception of culture) leading to Botswana’s 90-90-90 
achievement, it is imperative that SSA countries looking to adapt and implement lessons 
from the Botswanan HIV experience ensure they have a sustainable resource flow. 
Botswana’s response to its physician shortage may serve as an example of adapting 
practices within the confines of resource constraint. The introduction of nurse-led 
prescribing, as discussed in the literature review, increased rural area reach and 
counteracted the physician shortage, helping to ensure more PLHIV could engage in care 
and treatment. While nurse-led prescribing may not be a workable solution in some SSA 
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countries, the practice of finding alternative prescribing methodologies may be an 
implementable learning.  
Additionally, a community-based approach to behavior change was noted in both the 
literature review and by KII’s as a factor compelling Botswana’s 90-90-90 achievement. It is 
unlikely that reproducing a community-based approach in other SSA countries exactly as 
conducted in Botswana would yield the exact same results. For example, in SSA countries 
where girls cannot go to school, HIV education in schools may not have the effect that it did 
in Botswana. To have an effect on school-age children similar to the Botswanan experience, 
SSA countries must evaluate where and how HIV education can be most effective within the 
context of their country setting. Likewise, introducing opt-out HIV testing must be balanced 
against the availability of resources to treat every person who tests positive for HIV. In 
countries where resource devoted to HIV treatment is constrained, modifying the approach 
to include opt-out specifically for known sexual contacts of those infected with HIV may 
prove to be a more fit-for-purpose response until treatment resource constraint is removed. 
Perhaps the most adaptable and implementable cross-cultural resource-centered 
lesson based on Botswana’s HIV experience is the systematic analysis of trends and gaps in 
HIV planning, program implementation, and funding to determine the cost effectiveness of 
HIV program options and strategies. Development of a modelled investment case can be 
undertaken by any country to reflect its cultural, political, and resource priorities. Using the 
Botswana 2016 HIV Investment Case as a framework, any SSA country can produce a 
situational analysis of its HIV response, perform a modelling exercise, use the model to 
prioritize areas for strategic investment, and uncover the fiscal and economic implications. 
This type of exercise can provide the justification to refocus the HIV response, reallocate 
funding resources, and identify the interventions most likely to deliver the greatest impacts 
geared toward HIV epidemic control.  
Adaption and implementation of data collection lessons learned from both the 
UNAIDS data collection methodology analysis and from KII’s could come in the form of SSA 
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governments and international donors renewing their commitment to use standardized data 
collection and reporting methodologies. This analysis is reinforced by the conclusions of 
Granich et al. that improvements to data collection and reporting can be made by 
standardizing the meaning of “diagnosed HIV,” “receiving ART,” “on ART,” and “viral 
suppression”. To standardize these meanings, clearly defined and agreed numerators and 
denominators for each 90 must exist across SSA and the rest of the world. 
Moreover, the development of individual patient identifiers in SSA countries may also 
help enable the production of accurate national and subnational care continua. However, 
creation of individual patient identifiers should be balanced against the risk of creating a 
national database used to stigmatize and oppress PLHIV. Lastly, prioritization and 
standardization of population-based household-level surveys to corroborate NAP data and 
monitor 90-90-90 progress and sustainment would support SSA countries in achieving HIV 
epidemic control. 
Conclusions 
Strong targets and indicators have always been and continue to be required to 
control the HIV epidemic. Current targets, including 90-90-90, are geared toward ending 
HIV/AIDS as a public health threat by 203051. 90-90-90 is a step in a series of distinct stages 
moving towards HIV epidemic control. Starting with the Millennium Development Goals in 
2000, followed by two Security Council resolutions and three subsequent United Nations 
Political Declarations and the 2011 call from global leaders to provide 15 million people with 
life-saving HIV treatment by 2015, 90-90-90 is the current goal designed to galvanize action 
to combat HIV – and it won’t be the last. 90-90-90 will be followed by 95-95-95, with the goal 
of achieving global epidemic control by 2030. 
At the moment, achieving and maintaining viral suppression is the key to stopping 
HIV transmission and the HIV epidemic. The lynchpin in safeguarding 90-90-90 gains and 
HIV epidemic control in perpetuity is ensuring the sustainability and effectiveness of NAP’s 
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globally (and especially in SSA). Should either sustainability or effectiveness of any country’s 
NAP be compromised, viral suppression will decrease, HIV transmission will increase, and a 
new era of the HIV epidemic will begin. This means that even when epidemic control is 
realized, continued commitment, monitoring, and evaluation, will be required to sustain 
recent gains.  
Successful 90-90-90 target attainment, and ultimately, HIV epidemic control must 
employ interventions reflective of the local culture, context, and environment and include 
sustainable resourcing and focus on key populations. HIV interventions that work to progress 
90-90-90 in Botswana may have greater impact if the intervention is adapted, localized, and 
optimized to the geography where it will be implemented.  
Limitations of This Research 
Limitations to this study include those detailed in the literature review. General 
limitations of this study include using UNAIDS as the sole quantitative data source, as this 
confines the robustness of quantitative 90-90-90 insights. While UNAIDS is considered the 
gold standard for HIV data, future research may be benefit by understanding the precise HIV 
data collection methodologies on a per country basis which are not currently available in the 
public domain. The lack of available documentation created a deficiency in understanding 
what data were used to confer Botswana’s 90-90-90 achievement. The PI extrapolated 
UNAIDS data collection methodologies, and the fact that the latest Botswana AIDS Impact 
Survey, a national population-based household sexual behavior survey, has not yet been 
published, to develop the assumption that conference of Botswana’s 90-90-90 achievement 
was based on modeled results; this assumption, however, was not validated.   
Additionally, the inherent constraints of small KII sample size, sampling methodology, 
and participation added sample and selection bias. This limitation was partially addressed 
through mapping the HIV NAP organizational ecosystem into categories and groups 
(detailed in Table 5); however, while stakeholders from each category participated in the 
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KII’s, the PI was limited in and could not access specific organizations within the stakeholder 
groups that likely would have had valid insights into Botswana’s 90-90-90 achievement. 
Specific limitations to this study were introduced by the dual role of the PI being a 
student and an employee at an HIV drug developer and manufacturer. To limit this as a 
potential conflict of interest, the PI fully disclosed this information to all interview participants 
and did not explore HIV treatment milestones nor innovation, a potentially major factor 


















CHAPTER 7: AN APPROACH TOWARD HIV EPIDEMIC CONTROL READINESS 
90-90-90 is a stepping stone toward HIV epidemic control. As SSA countries change 
and increase the sustainability and effectiveness of their HIV response, their progress 
toward achieving 90-90-90, and ultimately HIV epidemic control, will intensify. Based on the 
lessons learned from Botswana’s 90-90-90 achievement and the concepts of resource, 
setting description, and key populations that underpin this study’s conceptual framework, the 
PI developed an approach to evaluate and adapt the sustainability and effectiveness of the 
HIV response in 46 SSA countries. This approach includes creation of a model given the 
name the HIV Epidemic Control Readiness Framework (HECRF) and a discussion of its 
application. The HECRF correlates lessons learned from the Botswana’s 90-90-90 
achievement to 13 economic and social indicators which, in their composite form, signal the 
effectiveness and sustainability of a country’s HIV program. Data for the 13 indicators was 
collected across 46 countries comprising Eastern, Southern, Western, and Central Africa 
and plotted into a simplified visual (Figure 9: SSA HIV Epidemic Control Readiness Chart) 
and a detailed scorecard (Table 8: SSA HIV Epidemic Control Readiness Scorecard). The 
approach towards HIV epidemic control is designed so SSA countries can leverage lessons 
learned from the Botswanan HIV experience and adapt/ localize solutions to improve the 
sustainability and effectiveness of their own NAPs. 
Two factors impact the applicability of the approach toward HIV epidemic control 
readiness: 1) Botswana’s deviation from the cultural and economic backdrop present in 
many other SSA countries and its characterization as an outlier within the region; 2) limited 
suitability of Western change models and frameworks to drive transformation in SSA. These 
factors are explored in greater detail in Limitations to the HECRF and Approach Toward HIV 
Epidemic Control Readiness section of this chapter. 
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HIV Epidemic Control Readiness Framework 
HIV program sustainability, or the ability of a country to run its NAP in perpetuity, and 
effectiveness, or the degree to which a country can successfully produce, augment, and 
surpass 90-90-90 results, are the cornerstones of HIV epidemic control. The HIV Epidemic 
Control Readiness Framework (HECRF) aims to frame a mix of qualitative and quantitative 
factors in 46 SSA countries to characterize the sustainability and effectiveness of their 
approach to HIV.  
Effectiveness, in the context of the HECRF, is the degree to which a country’s 
setting (e.g. its environmental backdrop, including political will, cultures and norms, laws, 
policies, actions, behaviors, health mechanisms, and infrastructure) and focus on key 
populations supports or degrades progress towards HIV epidemic control. 
Sustainability, in the context of the HECRF, is defined as a country’s capacity to 
maintain HIV programs that drive towards, and ultimately beyond, 90-90-90 viral suppression 
target achievement even after the removal of external funding. The sustainability of a 
country’s HIV response hinges on country-level political and economic engagement, as well 
as the resources dedicated to fighting and controlling HIV/AIDS. 
Using the conceptual model and insights informed by the literature review and 
quantitative and qualitative arms of this study, in addition to using HIV prevalence and 90-
90-90 achievement scores as indicators, the PI identified a set of 12 HIV epidemic control 
readiness metrics; eight metrics are focused on two key aspects of HIV epidemic control 
effectiveness and four metrics on one aspect of HIV epidemic control sustainability. Table 6 
depicts the HIV epidemic control readiness metrics. 
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Table 6: HIV Epidemic Control Readiness Metrics 
 
The selection of indicators was guided by the following criteria: 1) quantitative 
depiction of the qualitative conceptual framework factor being measured (e.g. setting 
description, key populations, resources); 2) data collected and published by independent, 
reputable, and reliable institutions; 3) data are publicly available and easily accessible; and 
4) comparable across SSA countries over time. Table 7: HIV Epidemic Control Readiness 
Indicator Sources details the origin of the indicator and data. 
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Table 7: HIV Epidemic Control Readiness Indicator Sources 
 
The HIV Epidemic Control Readiness Chart 
The HIV epidemic control readiness indicators were statistically normalized through a 
process detailed in the Data Techniques and Analysis section of this chapter and plotted on 
a simplified visual, Figure 9: SSA HIV Epidemic Control Readiness Chart. The Figure depicts 
the aggregated data in four dimensions:1) prevalence of each countries’ HIV epidemic (the 
size of the circle), 2) how close the country is to achieving 90-90-90 (the color of the circle), 
3) the effectiveness of the HIV programs (the x-axis), and 4) the sustainability of the country 
HIV programs (the y-axis).  
The effectiveness axis on the SSA HIV Epidemic Control Readiness Chart measures 
the degree to which a country’s setting and focus on key populations work together to 
support achieving the 90-90-90 targets, and ultimately, HIV epidemic control. The 
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sustainability axis measures a country’s capacity to drive HIV epidemic control even after the 
removal of external funding. 
The SSA HIV Epidemic Control Readiness Chart is a tool for countries to identify: 1) 
their HIV prevalence, relative to other SSA countries, 2) where they score relative to other 
SSA countries in their progress towards 90-90-90 and HIV epidemic control 3) where they 
score relative to other SSA countries in the sustainability and effectiveness of their HIV 
programs, and, 4) where increased focus or change agency - in areas related to HIV 
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SSA HIV Epidemic Control Readiness Indicators 
The HECRF measures two aspects of country HIV response effectiveness – setting 
description and key population focus – using eight indicators. The country setting description 
draws on lessons learned from Botswana’s 90-90-90 achievement and is defined by the 
political will, cultures and norms, laws, policies, actions, behaviors and health mechanisms 
that combine to support or deter progress toward HIV epidemic control. The setting is 
measured by the Human Development Index (HDI), Corruption Perception Index (CPI), 
number of physicians and nurses per 1,000 people, and implementation of national policy on 
viral load monitoring. Key population focus is defined by the laws and policies that support or 
neglect marginalized, highest-risk, priority and/or vulnerable populations, and is measured 
by if and to what degree countries criminalize homosexuality and sex work, as well as to 
what level a country has adopted the WHO key population guidelines. 
The sustainability of a country’s HIV response is defined by the dedicated economic 
and financial resources required to achieve the 90-90-90 targets and epidemic control and is 
measured using four indicators: GNI per person, domestic government health expenditure, 
share of domestic resources in HIV spend, and donor dependency in total HIV spend. The 
effectiveness and sustainability indicators are described in detail, along with their relevance 
to HIV epidemic control readiness, below.  
Country HIV Response Effectiveness Metrics 
Setting Description 
1) Human Development Index (HDI) 
The HDI is a global index compiled by the UN Development Program (UNDP) and is a 
summary measure of achievement in key dimensions of human development: a long and 
healthy life, being knowledgeable, and having a decent standard of living52. Using life 
expectancy at birth to assess health, mean of years of schooling for adults aged 25 and up 
and expected years of schooling for school-age children as a barometer for education, and 
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Gross National Income (GNI) per person to assess standard of living, the scores for the 
three HDI dimensions are aggregated into a composite index using geometric mean. 
Using quantile regression, studies have shown that low HDI countries have had higher 
HIV/AIDS mortality, prevalence, and incidence rates than that of medium, high, and very 
high HDI countries, and that human development has been a significant factor on the 
HIV/AIDS epidemic, as shown in countries where the epidemic is most severe53. Using the 
HDI as an indicator to inform HIV epidemic control readiness provides a mechanism to 
assess the relationship between HIV and human development. 
2) Corruption Perception Index (CPI) 
The CPI, developed by Transparency International, scores and ranks countries and 
territories based on how corrupt a country’s public sector is, as perceived by experts and 
business executives54. The 2018 CPI is a composite index drawing from 13 data sets from 
12 reputable institutions specializing in governance and business climate analysis54. 
Appendix Table 1 (AT1) details the sources of information used to inform the 2018 CPI. 
The corruption within a country is linked to its ability to attract and retain donor funding, 
as well as the trust, intent, and ability to implement robust NAP’s. Corruption in the health 
sector affects poor people and key populations the most, and can mean the difference 
between life and death55. Without proper checks from regulators, public health funds can 
easily disappear. World Bank surveys have shown that in some countries, up to 80% of non-
salary health funds never reach local facilities55 and PLHIV can therefore be denied care and 
treatment.  
3) Number of Physicians per 1,000 people and 4) Number of Nurses per 1,000 people 
The World Bank collects data regarding the number of physicians per 1,000 people56 and 
the number of nurses per 1,000 people57.  
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Nowhere is the deficit of human resources for health care more severe than in SSA, 
where the ratio of health care workers to the population is the lowest worldwide58. ART 
coverage is directly linked to the density of health care workers58. 46 countries in SSA have 
significantly less than 2.28 physicians or nurses per 1,000 people, which is widely regarded 
as the minimum threshold required to deliver basic health services58. SSA countries with the 
lowest ART coverage rates also have the lowest density of health care workers58. Lack of 
resources, including health care workers, contributes to an inability of countries to scale up 
rates of ART coverage; in fact, to deliver ART on a national scale, many SSA countries, such 
as Rwanda, would require their number of health care workers to increase by as much as 
50%58. 
5) Implementation of national policy on viral load testing 
The WHO uses the GAM, Spectrum estimates, and the WHO HIV Country Intelligence 
Tool to gather data on how completely a country has implemented a national policy for viral 
load testing59. 
Viral load testing and monitoring is the cornerstone of HIV epidemic control and the 
ability to measure treatment as prevention. National policies on viral load testing help ensure 
that PLHIV have viral loads that remain undetectable and non-infectious to others.  
Key Population Focus 
6) Decriminalization of homosexuality 
The International Lesbian Gay Bisexual Trans and Intersex Association (IGLA) publishes 
a world survey of sexual orientation laws in its State-Sponsored Homophobia Report60. The 
2019 IGLA report details the criminalization of same-sex acts on a per country basis. 
The risk of acquiring HIV is 22% higher in MSM4. Moreover, the criminalization, 
marginalization and oppression of the MSM population drives them underground, reduces 
their access to services and increases risk-taking behavior. The decriminalization of 
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homosexuality is an important step in ensuring access to medicine, treatment, and viral 
suppression of MSM who are HIV positive. 
 
7) Decriminalization of sex work 
The Institute of Development Studies: Sexuality, Poverty and Law Program has mapped 
the national “legal frameworks” regarding sex work with the aim of providing an accurate 
overview of the laws, regulations, directives and enforcement practices that govern the sale 
of sexual services by adult women61. 
The risk of acquiring HIV is 21 times higher for sex workers4. Moreover, sex workers in 
SSA experience high levels of poverty, violence, the inability to negotiate safe sex, a 
significant disease burden, and lack of access to health facilities and ART62. Additionally, 
health care workers who lack training in how to treat sex workers can fuel stigmatization62. In 
turn, sex workers will often be unwilling to test for HIV and to access ART62. The 
decriminalization of sex work is critical in ensuring this oppressed and marginalized group of 
people can access HIV treatment without fear of legal retribution. 
8) Adoption of WHO key population guidelines 
The WHO uses the GAM, Spectrum estimates, and the WHO HIV Country Intelligence 
Tool to gather data on how completely a country has adopted WHO key population 
guidelines59. 
Key populations are defined by the WHO as those who are “higher risk for HIV 
irrespective of the epidemic type or local context and who face social and legal challenges 
that increase their vulnerability62.” Sex workers, MSM, transgender people, people who inject 
drugs, and people in prison and other closed settings are considered key populations and, 
historically, have not received adequate priority in HIV response, specifically in SSA62. Full 
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implementation of the WHO guidelines on key populations signals political will to prioritize 
and care for the populations at the greatest risk of contracting and transmitting HIV. 
Country HIV Response Sustainability Metrics 
9) Gross National Income (GNI) per person (Atlas Method) 
The World Bank (WB) has used the Atlas method to estimate the size of economies, in 
US dollars, since 1993. However, calculating GNI using Purchasing Power Parity (PPP) 
ensures a more accurate reflection of people’s living standards52 – but this calculation 
methodology is already accounted for in the HDI. GNI in real terms (i.e. Atlas method 
calculation) is an important indicator in understanding varying degrees of wealth between 
countries. Studies have shown that poverty makes people more vulnerable to AIDS, that 
AIDS generates poverty, and that a negative correlation exists between GNI per capita and 
HIV/AIDS mortality, prevalence, and incidences rates53.  
The GNI Atlas method is what the Global Fund uses to project transitioning countries out 
of HIV funding63. Furthermore, this method signals a country’s capacity to pay for ART and 
program scale-up without reliance on donors or external forces.  
10)  Percentage of general domestic government health care expenditure (as a percentage of 
general government expenditure) 
The World Bank expresses the percentage of domestic general government health 
expenditure as a percentage of general government expenditure across all countries64. This 
signals the relative priority health has over other sectors of government spend. Instead of 
evaluating political means (as GNI can), the percentage of general domestic government 
health care spend is a quantifiable proxy for political priority. 
11)  Share of domestic resources in HIV spend and 12) donor dependency in total HIV spend 
The GAM tool is one of the portals country’s use to input data on HIV expenditure18. This 
data includes the US dollar amount of domestic spend (divided into public and private 
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spend) and international donations (categorized by international donating agency). Using the 
raw data, the PI calculated the share of domestic resources versus donor-initiated resources 
to serve as an analogue for country-level commitment to HIV and reliance on external forces 
to shape and maintain the NAP, respectively. These factors signal the sustainability of the 
HIV response since countries (like Botswana) that can self-fund their HIV programs have 
more control over how they allocate funds, can be more selective in their HIV response, and 
can localize their approach more than countries who rely on donor funding. 
SSA HIV Epidemic Readiness Control Scorecard 
Data from the HIV epidemic control readiness indicators were aggregated, 
statistically assessed for correlation, normalized, and arranged into a scorecard, Table 8: 
SSA HIV Epidemic Control Readiness Scorecard. On the normalized scorecard, the score of 
100 always signals the most advantageous country position, and a score of 0 always signals 
the least advantageous country position. By identifying low scoring areas, the normalized 
scorecard is a tool to determine where increased focus or change could improve HIV 
epidemic control readiness in SSA.
 
1 
Table 8: SSA HIV Epidemic Control Readiness Scorecard 
The score of 100 
always signals the 
most advantageous 
country position, 
and a score of 0 
always signals the 
least advantageous 
country position 
SUSTAINABILITY INDICATORS EFFECTIVENESS INDICATORS 
HIV 
Prevalence 












































ization of sex 
work 
Adoption of WHO 
key population 
guidelines 
REGION/COUNTRY EASTERN AFRICA 
Comoros 100 7 7 16 16 26 34 9 16 100 0 0 50 
Eritrea 98 3 2 26 26 21 19 2 9 100 0 0 0 
Ethiopia 97 3 23 18 18 40 25 0 2 100 0 0 50 
Kenya 83 9 23 37 37 26 53 9 28 100 0 0 0 
Madagascar 99 1 100 5 5 23 37 6 2 50 100 0 50 
Malawi 65 1 48 3 3 36 28 0 3 100 0 100 50 
Mauritius 100 77 48 76 76 72 98 100 63 100 0 0 0 
Mozambique 55 1 38 3 3 19 19 2 5 50 100 100 0 
Rwanda 90 3 41 9 9 81 38 2 14 100 100 0 50 
Seychelles 100 100 49 100 100 100 100 49 84 0 100 0 0 
South Sudan 92 1 0 35 35 0 8 0 0 50 0 0 50 
Uganda 79 2 17 13 13 25 37 4 10 100 0 0 50 
United Republic of 
Tanzania 84 5 45 46 46 43 42 0 5 50 0 0 50 
Zambia 58 8 30 8 8 42 53 4 15 100 0 0 50 































































ization of sex 
work 
Adoption of WHO 
key population 
guidelines 
REGION/COUNTRY SOUTHERN AFRICA 
Angola 93 20 19 18 18 11 51 6 26 50 100 0 50 
Botswana 17 49 43 64 64 91 82 18 51 100 0 0 50 
Eswatini 0 23 83 0 100 47 53 6 25 100 0 0 100 
Lesotho 13 7 55 18 18 53 37 1 9 100 100 100 50 
Namibia 56 32 74 71 71 75 66 18 52 100 0 0 50 
South Africa 32 36 70 79 79 57 78 40 100 100 100 0 100 
REGION/COUNTRY WESTERN AFRICA 
Benin 97 4 7 14 14 51 36 7 9 50 100 0 50 
Burkina Faso 97 2 55 54 54 53 16 1 10 100 100 0 50 
Burundi 96 0 39 13 13 8 14 0 1 50 0 0 50 
Cape Verde 98 21 48 65 65 83 68 39 22 50 100 0 0 
Côte d'Ivoire 90 9 15 13 13 42 31 6 7 100 100 0 50 
Gambia 95 3 1 45 45 45 24 4 29 50 0 0 0 
Ghana 94 12 26 38 38 53 54 4 15 50 0 0 50 
Guinea 95 4 10 0 0 28 24 3 5 50 0 50 50 





The score of 100 
always signals the 
most advantageous 
country position, 
and a score of 0 
always signals the 
least advantageous 
country position 
SUSTAINABILITY INDICATORS EFFECTIVENESS INDICATORS 
HIV 
Prevalence 












































ization of sex 
work 
Adoption of WHO 
key population 
guidelines 
REGION/COUNTRY WESTERN AFRICA 
Liberia 95 2 8 0 0 36 18 0 6 50 0 0 0 
Mali 96 4 19 29 29 36 16 3 6 100 100 100 100 
Mauritania 99 6 19 38 38 26 37 2 10 50 0 0 0 
Niger 99 1 20 0 0 40 0 0 0 100 100 0 50 
Nigeria 90 11 16 4 4 26 40 19 29 100 0 0 100 
Senegal 99 7 23 26 26 60 34 2 3 100 0 0 50 
Sierra Leone 95 1 35 1 1 32 15 0 4 100 0 0 50 
Togo 93 2 11 19 19 32 34 2 3 100 0 0 50 
REGION/COUNTRY CENTRAL AFRICA 
Cameroon 87 8 2 40 40 23 46 3 8 100 0 0 100 
Central African 
Republic 86 1 16 14 14 25 3 1 2 50 100 100 0 
Chad 96 3 22 27 27 11 11 1 3 100 0 0 50 
Congo 89 9 9 72 72 11 57 4 13 50 100 0 0 
Democratic 
Republic of the 
Congo 
98 1 7 58 58 13 23 4 16 50 100 0 100 





The score of 100 
always signals the 
most advantageous 
country position, 
and a score of 0 
always signals the 
least advantageous 
country position 
SUSTAINABILITY INDICATORS EFFECTIVENESS INDICATORS 
HIV 
Prevalence 












































ization of sex 
work 
Adoption of WHO 
key population 
guidelines 
Gabon 85 43 43 94 94 34 79 20 54 50 100 0 0 
Sao Tome and 
Principe 
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Data Techniques and Analysis 
The PI downloaded comma separated value (CSV) files, available online, of the 
above data sets; where CSV files were unavailable, Selinium WebDriver, an open-source 
web-scraping tool, was used to locate the required data. The data were collated by joining 
International Organization for Standardization (ISO) country codes to the 46 countries in 
SSA and matching the data therein. In instances where data were missing, data were 
imputed using the fill-forward method, which carries forward the most recently recorded 
value of an indicator for a given country. Ordinal encoding was used to assign numerical 
values to qualitative variables (a description of how ordinal encoding was used can be found 
in Appendix Table 2 (AT2): Ordinal Encoding Description). 
Based on guidance from the European Union (EU), Organization of Economic 
Cooperation and Development (OECD) on constructing a composite indicator67,68 a min-max 
normalization procedure was evoked to facilitate scale comparisons and to preserve 
understanding as to how countries in SSA rank against each other on a per indicator basis. 
Calculation of Closeness 
A closeness measure was devised as a means of representing a country’s current 90-
90-90 status. Based on each countries’ progress toward 90-90-90, a modified version of the 
Euclidean metric (the most common way to evaluate multiple numbers) was used, with the 
following methods: 
- If a score was > 90, then a 90 was assigned to the value  
- The Euclidean distance was calculated on the adjusted statistics 
This step was undertaken to eliminate the circular nature of the Euclidean measure; 
without this modification, countries with scores higher than 90 would have finished with 
closeness scores greater than 0. The closeness calculation was used to inform SSA 
countries progress towards 90-90-90 on the HIV Epidemic Control Readiness Chart: 
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• Achieved (defined as all 3 scores being at or above 90): closeness score = 0 
• Really Close: closeness score = <10 
• Close: closeness score = <30 
• Not close: = >30   
Constructing Composite Indicators 
The Sustainability Index 
The sustainability index provides a numerical summary of a country’s capacity to drive 
toward, and ultimately beyond, 90-90-90 viral suppression target achievement, even after 
the removal of external funding. The mixture of GNI per person and domestic expenditure on 
health as a part of total government spend, with special emphasis on the latter, can be 
considered as follows: 
 
➢ Domestic expenditure on health as a part of total government spending is an 
analogue for government priority and economic commitment to controlling the HIV 
epidemic in a nation  
➢ GNI per person is an analogue for an individual’s capacity to afford treatment.  
 
To calculate the sustainability index, the PI first assessed the correlation matrix of the 
sustainability indicators. This matrix revealed that domestic expenditure on health as a part 
of total government spending, share of domestic resources in HIV spending, and share of 
donor resources in HIV spending are all heavily correlated. Indeed, in this study, share of 
domestic and donor resources in HIV spending were perfectly negatively correlated, due to 
how they were calculated. 
 Share of Donor = 1 – Share of Domestic 
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The Effectiveness Index 
The effectiveness index provides a numerical summary of a country’s capacity to 
facilitate HIV epidemic control as a result of the setting (defined by the political will, cultures 
and norms, laws, policies, actions, behaviors and health mechanisms that combine to 
support or deter 90-90-90 progress) and focus on key populations.  
Following the approach used by the USAID Self-Reliance Metrics FY 2019 
Methodology Guide69, the effectiveness index was calculated by assigning an equal weight 
to each of the indicators and taking the mean.  
Visualization 
The PI used Flourish, an open-source data visualization and storytelling platform to 
graph each country’s progress towards 90-90-90 achievement, the variables contributing to 
HIV epidemic control, and sustainability and effectiveness of their HIV programs. The bubble 
size represents the degree of HIV prevalence, while the color of the bubble represents how 
close the countries are to achieving 90-90-90 based on the closeness calculation.  
A min-max scaling technique was used to normalize all data onto a common 0-100 
scale to facilitate visualization, comparison across metrics, and calculation of the 
effectiveness and sustainability of HIV program response indices. A country score of 0 on a 
given metric indicates that the country recorded the worst possible outcome in SSA in the 
raw data set (see Appendix Table 3 (AT3): SSA HIV Epidemic Control Readiness Raw 
Data), and a country score of 100 on a given metric indicated that the country scored the 
best possible outcome in SSA in the raw data set. The original source data distribution was 
preserved by all other countries (beyond the worst and best performers) receiving scores 
within the 0-100 range, based on where they fall within the worst and best outcomes in SSA. 
The collective data used the most recently available information from each source. 
To account for higher raw numbers being more advantageous (GNI per capita), while 
lower numbers are more advantageous (donor dependency in overall HIV health care 
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spend), the PI aligned or “flipped” the directionality of scores across the 13 metrics so that, 
when converting each set of raw data, a score of 100 always represented the most favorable 
position for HIV epidemic control readiness and a score of 0 always represented the least 
favorable country position.  
Implications 
There are no existing data set that can accurately measure each countries’ unique 
cultural, social, political, or economic foundation completely or perfectly. The selection of HIV 
epidemic control readiness metrics is intended to provide a snapshot in time of some of the 
variables compelling and precluding 90-90-90 achievement and HIV epidemic control 
readiness at a country level. Examination of these data should be complemented by analysis 
of other quantitative and qualitative information, as well as a deep understanding of a 
country’s cultural, social, political, and economic underpinnings, to ensure the full picture of 
that country’s HIV/AIDS response is understood.  
Credibility of the composite indicator construction is driven by nuances within the SSA 
HIV Epidemic Control Readiness Chart (Figure 9): 
1. Country proximity to 90-90-90 target achievement (represented by the color of the 
dots) generally increases along the sustainability and effectiveness axes, 
culminating in the upper right quadrant of Figure 9. This is especially true for 
countries with high HIV prevalence (represented by the size of the dots) where 
sustained focus on the HIV epidemic is required to achieve epidemic control.  
2. SSA countries with low HIV prevalence (represented by the small dots on the HIV 
Epidemic Control Readiness Chart) may not prioritize the HIV epidemic; this is 
demonstrated on the chart, which indicates some countries with sustainable and 
effective NAP capacity and with low prevalence (Mauritius and Seychelles) are not 
on track to achieve the 90-90-90 goals. 
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3. The three countries in SSA having achieved 90-90-90 (Botswana, Namibia, and 
Eswatini) show a similar high degree of prevalence and, based on the isolated 
cluster in which they sit on the SSA HIV Epidemic Control Readiness Chart 
(midway between both sustainability and effectiveness), demonstrate that resource 
constrained countries can in fact achieve 90-90-90. The chart also demonstrates 
that countries which have achieved 90-90-90 have not achieved a fully sustainable 
and effective NAP; this means these countries must stay attuned to the factors 
compelling the effectiveness and sustainability of their NAP in order to preserve 
and augment their gains to ultimately achieve HIV epidemic control. This thus 
demonstrates the credibility of the composite sustainability and effectiveness 
indicators and the HECRF. 
The viability of the HECRF and the ensuing approach toward HIV epidemic control 
requires stakeholders interested in impacting HIV prevalence, progress towards 90-90-90, 
and HIV epidemic control readiness in SSA to be readily attuned to the cultural 
characteristics of the SSA countries they intend to impact by utilizing the framework. 
Ensuring HIV programmatic change is culturally aligned to the environment in which the 
change is targeted helps secure more effective and sustainable results. In regard to this 
study, cultural alignment to the factors determined to compel 90-90-90 requires adapting, 
localizing, and acculturating lessons learned from the Botswanan HIV case study to other 
countries in SSA. 
Limitations to the HECRF and Approach Toward HIV Epidemic Control Readiness 
Botswana’s deviation from the cultural and economic backdrop present in many other 
SSA countries and limited suitability of Western change models and frameworks to drive 
transformation in SSA restrict the applicability of the HECRF and this study’s approach 
toward HIV epidemic control. Botswana’s stable democracy, cultural priorities inclusive of 
partnership and political will with the intent to care for the country’s most vulnerable, and 
UMIC country classification distinguish the country as an outlier within the context of SSA. 
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Assessment of interventions used by Botswana to impact the indicators contained in the 
HECRF and their applicability (i.e. whether a Botswanan intervention could be implemented 
in a different SSA country) and transferability (i.e. whether it would be as effective in another 
SSA country as it was in Botswana) to specific SSA countries is beyond the scope of this 
study. This is because applicability and transferability of successful HIV interventions in 
Botswana to other SSA countries can only be known by understanding the capacity, beliefs 
and values, culture, and previous experience of the country for which the intervention is 
intended. Without this understanding, interventions may be inappropriately introduced to 
SSA countries where the benefits seen in Botswana would not be replicated. It is for this 
reason that lessons, practices, and interventions learned from the Botswana HIV experience 
must be adapted and acculturated to the environment and SSA country to which they are 
targeted.  
Few studies explore the applicability, adaptability, and transferability of public health 
research in low-resource settings65 and, due to their Western bent, existing theories and 
frameworks for change may not reflect the factors considered most relevant by SSA 
countries looking to change their HIV epidemic control readiness. Numerous organizational 
and change theories have been proposed in literature to facilitate the adoption of key 
theoretical insights into the design and implementation of health promotion in diverse 
settings; these include, but are not limited to: Diffusion of Innovations, Organizational 
Learning, Organizational Culture and Leadership, Action Research, the Three-step model 
and Field Theory, Receptive Contexts for Change66, John Kotter’s 8-step change model, and 
William Bridges 3-step change model66. However, all of these change theories and 
frameworks were developed by Western researchers coming from developed world 
countries and therefore use a Western lens to invoke change. While the explanatory factors 
of these change theories may provide a useful starting point, the theories do not appear to 
have been developed based on the views of potential users in low-resource settings, like 
SSA. Appendix Table 3 (AT3): Change and Organizational Theorists, Theories, and 
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Explanatory Factors details the organizational and change theorists, theories/frameworks, 
and the principles underpinning the aforementioned organizational and change management 
theories.  
It is with these limitations in mind that stakeholders in and outside of Botswana 
looking to impact HIV prevalence, drive toward 90-90-90, and achieve HIV epidemic control 
should leverage the HECRF and the approach toward HIV epidemic control readiness. 
Application of HECRF and Approach Toward HIV Epidemic Control Readiness 
The original intent of the PI was to leverage lessons learned from the Botswanan HIV 
experience and personally catalyze change in SSA countries through her role working with 
HIV NAP’s and MOH’s in SSA. However, due to changes in professional responsibilities, the 
PI has moved away from working in HIV/AIDS and now leads the analytical focus and 
development of broader global health strategies at GSK, a global pharmaceutical company. 
Currently, the PI evaluates, creates, and implements strategies to drive access to 
tuberculosis (TB) treatment and care. However, future roles, responsibilities, and 
opportunities may present themselves for the PI to be an advocate for HIV. Given the 
inextricable link between TB and HIV, and based on the outcomes of operationalizing the 
HECRF, potential exists for the PI to adapt the framework to be fit-for-purpose to TB.  
The HECRF includes the SSA HIV Epidemic Control Readiness Chart and 
Scorecard; these tools are designed for stakeholders interested in and working amongst 
SSA NAP’s and provide a simplified view of where SSA countries are doing well and where 
they can improve in their HIV epidemic control readiness. The following steps may be 
employed to utilize these tools:  
1. Determine the SSA country for HIV epidemic control readiness evaluation 
2. Locate the selected SSA country’s position on the HIV Epidemic Control Readiness Chart 
(Figure 9) 
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3. Based on the following criteria, determine if the selected SSA country should focus on 
improving the sustainability or effectiveness of their HIV programs: 
i. Countries in the lower left quadrant of the SSA HIV Epidemic Control Readiness 
Chart: HIV program sustainability and/or effectiveness can be improved 
i. Countries in the upper left quadrant of the SSA HIV Epidemic Control Readiness 
Chart: HIV program effectiveness can be improved 
ii. Countries in the lower right quadrant of the SSA HIV Epidemic Control Readiness 
Chart: HIV program sustainability can be improved 
iii. Countries in the upper right quadrant of the SSA HIV Epidemic Control Readiness 
Chart: demonstrate sustainable and effective HIV programs and should focus on 
their lowest scores across the SSA HIV Epidemic Control Readiness Scorecard to 
make demonstrable gains in their 90-90-90 achievement and/or HIV epidemic control 
readiness 
4. Locate the selected SSA country on the SSA HIV Epidemic Control Readiness 
Scorecard and, based upon the determination in step 1C, assess which sustainability 
and/or effectiveness indicators would be the most efficacious, practical, and feasible to 
change using local solutions.  
The approach towards HIV epidemic control readiness requires acculturating the HECRF 
to the country in which it is targeted. Acculturation of the HECRF may be informed by 
several organizational and change theories and must be undertaken with consideration to 
the limitations previously described. Axioms underpinning the approach toward HIV epidemic 
control include, but are not limited to, principles defined by: 
• Edgar Schien’s Organizational Culture and Leadership Theory, including: culture can 
be observed and studied through the behavior of groups and their beliefs, values, 
and assumptions; the culture of the organization determines its actions; culture is 
formed over time through shared experiences within groups66. 
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• Andrew Pettigrew, Ewan Ferlie and Lorna Mckee’s Receptive Contexts for Change 
Theory, including: the degree to which a public sector institution is amenable to 
change depends on a combination of variables that are associated with the process 
and setting for change. These include quality and coherence of policy; availability of 
key people leading change; long-term environmental pressure; supportive 
organizational culture; effective managerial-clinical relations; cooperative inter-
organizational networks; simplicity and clarity of goals and priorities; and fit between 
the change agenda and its locale66. 
• Chris Argyris and Donald Schon’s Organizational Learning Theory, including: the 
learning type of the organization and its members influences the acceptance of 
change. Organizational environments with a propensity towards defending existing 
norms have different capacity for learning and growth compared with organizational 
environments that are open and reflective66. 
Stakeholders interested in moving SSA countries towards HIV epidemic control 
readiness must assess whether the practices and factors compelling 90-90-90 achievement 
in Botswana are appropriate for use in the country in which they are looking to effect change. 
Further, stakeholders must adapt and acculturate the lessons learned from the Botswanan 
HIV experience to the setting, context, and culture of the SSA country targeted for HIV 
epidemic control readiness change. Table 9: Ways for Stakeholder Groups to Utilize the 
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Table 9: Ways for Stakeholder Groups to Utilize the HECRF 
Stakeholder Groups 
Responsible for ART 
Program Implementation 
and HIV Patient Care 
Ways to Utilize the HECRF 
SSA country NAP officials Identify HECRF indicators and areas for improvement; determine 
appropriate steps and resources required; determine what should 
be adapted from the Botswanan HIV experience, make the changes 
to improve 90-90-90 target achievement and progress toward HIV 
epidemic control  
Non-government officials 
who partner with/ advise 
the NAP 
Identify HECRF indicators and areas that align with expertise; 
determine how to actualize efficient and effective change in the 
selected areas; advise NAP officials on making the change based on 
the relevant cultural characteristics of the SSA country to which the 
change is targeted 
HIV healthcare 
practitioners 
Focus on key population indicators and determine how to improve 
access and care within their own practice 
Not-for-profit NAP 
implementing partners 
Identify HECRF indicators and areas that align with the intervention 
the NGO is responsible for; determine how to actualize efficient and 
effective change within the selected indicator/ area and based on 
the context of the country to which the change is intended; develop 
and secure proposals to make the change ensuring the proposed 
intervention is validated by in country stakeholders as acculturated 
to the SSA country to which the proposal is intended 
For profit NAP 
implementing partners (e.g. 
corporations) 
Identify HECRF indicators and areas that correlate with increased 
sales and access to products and/or drive corporate commitments; 
lean on NAP’s and non-government officials who partner with/ 
advise the NAP to acculturate, develop, and execute innovative 
ways to drive product access/ corporate commitments 
Global bodies dedicated to 
HIV epidemic control (e.g. 
UN, WHO) 
Identify HECRF areas where most SSA countries demonstrate low 
performance on the SSA HIV Epidemic Control Readiness Scorecard; 
develop policies and guidelines that promote score improvement 
Global HIV funders Identify HECRF areas where funded SSA countries demonstrate low 
performance; lean on NAP’s and partners to acculturate 
interventions and practices to improve scores and fund, monitor, 
and evaluate the interventions 
In country implementing 
national HIV program 
partners  
Identify HECRF indicators and areas that align with the program the 
partner is responsible for; determine how to actualize efficient and 
effective change in the selected areas; develop, secure, and execute 
proposals to make the change ensuring they are acculturated to the 
SSA country to which they are targeted 
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Stakeholder Groups 
Responsible for ART 
Program Implementation 
and HIV Patient Care 
Ways to Utilize the HECRF 
Ex-country implementing 
national HIV program 
partners 
Identify HECRF indicators and areas that align with the program the 
partner is responsible for; lean on NAP’s and non-government 
officials who partner with/ advise the NAP to acculturate programs 
and practices; develop and secure proposals to make the change 
ensuring and validating with in country stakeholders that the 
proposal is fit-for-purpose to the SSA country in which it is targeted 
Academic institution 
affiliates partnering with 
the NAP 
Continue to iterate the HECRF using real work experience to inform 
the introduction of new HIV epidemic control readiness indicators 
HIV advocates and civil 
society 
Identify HECRF indicators and areas that align with the interventions 
that align with the groups advocacy strategy; utilize the quantitative 
approach employed by the HECRF to apply pressure for political 
change 
 
The viability and utility of the HECRF and approach toward HIV epidemic control 
readiness are contingent on effective acculturation of the framework to countries targeted for 
impact. Further work is now required to operationalize the framework set out in this paper. 
The HECRF can then be assessed in terms of its usefulness and appropriateness with a 
range of users.  
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APPENDIX AND SUPPLEMENTAL STUDY INFORMATION 
Appendix Exhibit 1 (AE1): Key Informant Interview Guide 
 Welcome 
 Thank you for agreeing to participate in this interview to discuss Botswana’s achievement of 
the UN 90-90-90 goals.  I am Courtney Lundquist, a student in the UNC Doctor of Public Health 
Program.  When I began this research I was working at the Commercial Lead in the Middle East, 
Africa, and Russia and Commonwealth of Independent States for ViiV Healthcare, a for-profit 
company dedicated to the treatment of HIV. I have since returned to GSK (an 80% shareholder of 
ViiV) as the Director of Global Health Access Analytics and Business Insights. As I indicated in the 
introductory letter, the information I collect as a part of this study is for my dissertation research and is 
not related to any current work at ViiV; however, the study results and data in aggregate may be 
shared with ViiV and/or GSK leadership and stakeholders. Additionally, I may publish portions of the 
dissertation, in which case the findings would become publicly available. Specifically, I am interested 
in getting your insight into how Botswana became one of the first countries to have achieved the UN 
viral suppression goal of 73% or greater for all people living with HIV (PLHIV). As the only country in 
sub-Saharan Africa to reach this achievement by July 2017, Botswana’s success is remarkable and 
understanding how this achievement occurred may help accelerate 90-90-90 achievement in other 
areas of the world. 
 In order to fully capture your responses today, I would like to record our conversation.  Do I have 
your permission to do so?  [If yes]: If you would like to have me stop the recording at any point in our 
conversation, please let me know and I will stop the recording. This interview should take between 45 
– 60 minutes. Again, it will be completely confidential and any information that you provide will be 
released as a summary or combined into general themes. Your name will not be connected to your 
answers in any way and digital audio files and transcripts will be confidentially destroyed at the end of 
the research study.  
Do you have any questions before we begin? 
Interview Questions 
I’d like to start by asking you about your organization and your role in it: 
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1. What is your job title and primary responsibility?   
2. How many years have you been with the organization? 
3.  Where are you primarily located? 
4. Please describe your experience in Botswana’s ART program implementation and/or HIV patient 
care 
I’d like to ask you about environmental attributes that facilitated or hindered Botswana’s 
achievement of 90-90-90: 
1. What interventions are responsible for Botswana’s attainment of 90-90-90? 
2. How do you determine appropriate interventions?  
3. How do you measure intervention outcomes? 
4. Do the interventions use local solutions? If so, what are they? 
[probe to understand if local solutions are specific to Botswana] 
5. How is the programmatic sustainability of the HIV program ensured? 
6. How is the financial sustainability of the HIV program ensured? 
[probe to understand how local capacity is strengthened and ability to address the problem in the long 
run? How is this measured?] 
7. For funding organizations: What are the criteria your organization uses to fund?  
[probe to understand what need to be seen to continue/ stop ensure sustainable funding?] 
8. Are there any additional thoughts or opinions about how Botswana achieved 90-90-90 that you 
would like to share?  
9. Are there any other stakeholders with expertise in the HIV epidemic in Botswana and/or country 
achievement of 90-90-90 that you would recommend I speak with about this topic? May I contact 
you again with follow up questions or for clarifications? 
Other potential/ probing questions 
• What interventions are used? 
• How are interventions selected? 
• Do the interventions use local solutions? If so, what are they? 
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• How does Botswana identify solutions themselves?  
• What process does Botswana use to reflect on the WHO guidelines?  
• What criteria/when/how does Botswana decide to not go with WHO recommendations?   
• What does the MOH/ Botswana guidelines committee do to make sure the intervention is 
appropriate to local considerations?  
• What does USAID/ WHO look at to determine appropriate interventions? 
• How does USAID/ WHO measure intervention outcomes? 
Case Study 
• Do WHO recommendations create dependency vs. building capacity? 
• Do internationally funded interventions (vs. locally funded interventions) strengthen local 
capacity and ability to address the problem in the long run? 
Conclusion 
 Thank you for your time today to discuss your opinions as to how Botswana achieved 90-90-
90.  The information and insights you shared will be valuable to my study. If you are interested, I 
would be happy to share the results of my research when the final report has been approved and 
accepted by UNC (expected Q4 2019). 
Appendix Table 1 (AT1): 2018 CPI Data Sources 
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Appendix Table 2 (AT2): Ordinal Coding Description 
 




Change Theory Explanatory factors 
Kurt Lewin Action Research, 
Field Theory, 3-
step model 
The status quo is the product of a number of forces in 
the social environment that govern individuals’ 
behaviour at a given point in time. As such causal 
relations can be analyzed. Change initiatives need to 
destabilize the status quo, implement the alternative 
and restabilize the environment. The implementation 
process involves research and performs a learning 
function. 
Everett Rogers Diffusion of 
Innovations 
Messages about new ideas are communicated within 
an organization and this brings about uncertainty. An 
organization’s propensity for innovation relates to 
structural factors within the organization, 
characteristics of individuals and external factors in the 
environment. 




The learning type of the organization and its members 
influences the acceptance of change. Organizational 
environments with a propensity towards defending 
existing norms have different capacity for learning and 
growth compared with organizational environments 
that are open and reflective. 
Edgar Schein Organizational 
Culture and 
Leadership 
Culture can be observed and studied through the 
behaviour of groups and their beliefs, values and 
assumptions. The culture of the organization 
determines its actions. Culture is formed over time 
through shared experiences within groups. 
  108 
Andrew 
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The degree to which a public sector institution is 
amenable to change depends on a combination of 
variables that are associated with the process and 
setting for change. These include quality and coherence 
of policy, availability of key people leading change, 
long-term environmental pressure, supportive 
organizational culture, effective managerial-clinical 
relations, cooperative inter-organizational networks, 
simplicity and clarity of goals and priorities, and fit 
between the district’s change agenda and its locale. 
John Kotter 8-step Process for 
Leading Change 
Change has both an emotional and situational 
component, and methods for managing each are 
expressed in an 8-step model (developing urgency, 
building a guiding team, creating a vision, 
communicating, for buy-in, enabling action, creating 




Change Theory Explanatory factors 
William Bridges Transition Model Change within a health care organization means that 
individuals must transition from one identity to a new 
identity when they are involved in a process of change. 





Appendix Table 4 (AT4): SSA HIV Epidemic Control Readiness Framework Raw Data 
 SUSTAINABILITY INDICATORS EFFECTIVENESS INDICATORS 
HIV 
Prevalence 

















































REGION/COUNTRY EASTERN AFRICA 






of sex work 
Partially 











of sex work 
Partially 






of sex work 
 






of sex work 
Partially 
Malawi 10% 360 10% 0.034709204 0.965290796 32 0.477 0.019 0.283 
Fully 
implemented NO 
 Sex work is not 
subject to punitive 
regulations or is 
not criminalized 
Partially 














 SUSTAINABILITY INDICATORS EFFECTIVENESS INDICATORS 
HIV 
Prevalence 

















































REGION/COUNTRY EASTERN AFRICA 
Mozambique 13% 440 8% 0.032376513 0.967623487 23 0.437 0.055 0.401 
Partially 
implemented YES 
 Sex work is not 
subject to punitive 
regulations or is not 
criminalized 
No 





Seychelles 0% 15600 10% 0.987320189 0.012679811 66 0.797 0.984 4.433  YES 
 Any criminalization 
or punitive 
regulation of sex 
work 
 
South Sudan 2% 460 0% 0.34632992 0.65367008 13 0.388   
Partially 
implemented NO 
 Any criminalization 
or punitive 
regulation of sex 
work 
Partially 
Uganda 6% 620 5% 0.131681961 0.868318039 26 0.516 0.093 0.648 
Fully 
implemented NO 
 Any criminalization 
or punitive 
regulation of sex 
work 
Partially 
United Republic of 
Tanzania 5% 1020 10% 0.452518878 0.547481122 36 0.538 0.022 0.416 
Partially 
implemented NO 
 Any criminalization 
or punitive 
regulation of sex 
work 
Partially 
Zambia 12% 1430 7% 0.086107433 0.913892567 35 0.588 0.091 0.886 
Fully 
implemented NO 
 Any criminalization 
or punitive 
regulation of sex 
work 
Partially 
Zimbabwe 13% 1790 15% 0.305751056 0.694248944 22 0.535 0.077 1.167 
Partially 
implemented NO 
 Any criminalization 
or punitive 









 SUSTAINABILITY INDICATORS EFFECTIVENESS INDICATORS 
HIV 
Prevalence 

















































REGION/COUNTRY SOUTHERN AFRICA 
Angola 2% 3370 5% 0.180575367 0.819424633 19 0.581 0.144 1.442 
Partially 
implemented YES  Partially 
Botswana 23% 7750 9% 0.632679362 0.367320638 61 0.717 0.384 2.727 
Fully 
implemented NO 
 Any criminalization 
or punitive 
regulation of sex 
work Partially 
Eswatini 27% 3850 15%   38 0.588 0.147 1.386 
Fully 
implemented NO  Fully 
Lesotho 24% 1380 11% 0.184933571 0.815066429 41 0.52 0.047 0.591 
Fully 
implemented YES 
 Sex work is not 
subject to punitive 
regulations or is not 
criminalized Partially 
Namibia 12% 5250 14% 0.705085679 0.294914321 53 0.647 0.374 2.775 
Fully 
implemented NO  Partially 
South Africa 19% 5720 13% 0.776868656 0.223131344 43 0.699 0.818 5.229 
Fully 
implemented YES 
 Any criminalization 
or punitive 
regulation of sex 
work Fully 
REGION/COUNTRY WESTERN AFRICA 
Benin 1% 870 4% 0.137841988 0.862158012 40 0.515 0.153 0.598 
Partially 
implemented YES 
 Any criminalization 
or punitive 








 SUSTAINABILITY INDICATORS EFFECTIVENESS INDICATORS 
HIV 
Prevalence 

















































REGION/COUNTRY WESTERN AFRICA 
Burkina Faso 1% 660 11% 0.535232605 0.464767395 41 0.423 0.047 0.63 
Fully 
implemented YES 
 Any criminalization 
or punitive 
regulation of sex 
work Partially 
Burundi 1% 280 9% 0.129691288 0.870308712 17 0.417 0.026 0.176 
Partially 
implemented NO  Partially 
Cape Verde 1% 3450 10% 0.639218752 0.360781248 57 0.654 0.788 1.256 
Partially 
implemented YES   
Côte d'Ivoire 3% 1610 5% 0.134325663 0.865674337 35 0.492 0.144 0.483 
Fully 
implemented YES 
 Any criminalization 
or punitive 
regulation of sex 
work Partially 
Gambia 2% 700 3% 0.444928257 0.555071743 37 0.46 0.107 1.618 
Partially 
implemented NO   
Ghana 2% 2130 7% 0.373511095 0.626488905 41 0.592 0.096 0.926 
Partially 
implemented NO 
 Any criminalization 
or punitive 
regulation of sex 
work Partially 












 SUSTAINABILITY INDICATORS EFFECTIVENESS INDICATORS 
HIV 
Prevalence 

















































REGION/COUNTRY WESTERN AFRICA 
Guinea-Bissau 3% 750 13% 0.116584462 0.883415538 16 0.455 0.045 0.551 
Partially 
implemented YES 
 Any criminalization 
or punitive 
regulation of sex 
work  
Liberia 1% 600 4% 0.004880753 0.995119247 32 0.435 0.023 0.456 
Partially 
implemented NO 
 Any criminalization 
or punitive 
regulation of sex 
work No 
Mali 1% 830 5% 0.291094296 0.708905704 32 0.427 0.085 0.443 
Fully 
implemented YES 
 Sex work is not 
subject to punitive 
regulations or is not 
criminalized Fully 
Mauritania 0% 1190 6% 0.373637951 0.626362049 27 0.52 0.068 0.667 
Partially 
implemented NO 
 Any criminalization 
or punitive 
regulation of sex 
work  
Niger 0% 380 6% 0.007705236 0.992294764 34 0.354 0.019 0.137 
Fully 
implemented YES 
 Any criminalization 
or punitive 
regulation of sex 
work Partially 







regulation of sex 
work Fully 



















 SUSTAINABILITY INDICATORS EFFECTIVENESS INDICATORS 
HIV 
Prevalence 

















































REGION/COUNTRY WESTERN AFRICA 







of sex work Partially 







of sex work Partially 
REGION/COUNTRY CENTRAL AFRICA 







of sex work Fully 
Central African 




 Sex work is not 
subject to punitive 
regulations or is 
not criminalized No 
Chad 1% 670 6% 0.269180182 0.730819818 19 0.404 0.044 0.309 
Fully 
implement
ed NO  Partially 







of sex work  
Democratic 
Republic of the 



































































REGION/COUNTRY CENTRAL AFRICA 
Equatorial Guinea 7% 7050 3% 0.929820264 0.070179736 16 0.591 0.252 0.447 
No policy 
on viral 
load testing YES  No 
Gabon 4% 6800 9% 0.929574323 0.070425677 31 0.702 0.406 2.898 
Partially 
implement
ed YES  No 
Sao Tome and 




 Sex work is not 
subject to 
punitive 
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